var title_f8_44_8896="The string wrap technique";
var content_f8_44_8896=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F69794&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F69794&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    String wrap method of ring removal",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 307px; height: 263px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The success of this technique depends upon tight, close wrapping of the digit or penis. Do not attempt this technique if the patient has ischemia of the digit or penis or an open wound, fracture, or dislocation distal to the ring. After appropriate analgesia, place one end of a 2.0 or 3.0 suture, Penrose drain, or umbilical tape 20 to 25 inches (0.5 to 0.6 m) in length under the ring from the proximal to the distal side with 5 inches (12.5 cm) of material remaining proximally. Wrap the suture material, drain, or tape tightly around the digit or penis beginning at the distal aspect of the ring. Overlap the wrappings so that no tissue is visible. Continue wrapping beyond the proximal interphalangeal joint of the digit or beyond the coronal sulcus of the penis. Once the wrapping is complete, pull on the proximal end of the wrapping material so that the ring is removed from the finger or penis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fuchs SM. Ring removal. In: Textbook of Pediatric Emergency Procedures, 2nd ed, King C, Henretig FM (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_44_8896=[""].join("\n");
var outline_f8_44_8896=null;
var title_f8_44_8897="Diacerein: International drug information";
var content_f8_44_8897=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"10\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Diacerein: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4302642\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Art (FR, IL);",
"     </li>",
"     <li>",
"      Artizona (CL);",
"     </li>",
"     <li>",
"      Artrodar (AR, BR, CZ, TH);",
"     </li>",
"     <li>",
"      Artrolyt (AT);",
"     </li>",
"     <li>",
"      Cartivix (PT);",
"     </li>",
"     <li>",
"      Fisiodar (IT);",
"     </li>",
"     <li>",
"      Galaxdar (ES);",
"     </li>",
"     <li>",
"      Glizolan (ES);",
"     </li>",
"     <li>",
"      Myobloc (GR);",
"     </li>",
"     <li>",
"      Ostirein (GR);",
"     </li>",
"     <li>",
"      Pentacrin (GR);",
"     </li>",
"     <li>",
"      Verboril (AT, GR);",
"     </li>",
"     <li>",
"      Zondar (FR)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F3460309\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Anthraquinone",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F3327166\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Osteoarthritis",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F3327168\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: Oral: 50 mg twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosage adjustment in renal impairment:",
"     </b>",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute: 25 mg twice daily",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821234\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F3327169\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Capsule: 50 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10487 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-B2407C6BAC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_44_8897=[""].join("\n");
var outline_f8_44_8897=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4302642\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3460309\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3327166\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3327168\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821234\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3327169\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10487\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10487|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_44_8898="Calcified intraorbital mass";
var content_f8_44_8898=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F72561&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F72561&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Calcified intraorbital mass",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 439px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This CT scan demonstrates a calcified intraorbital mass. The calcification makes retinoblastoma the most likely diagnosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Jeanne Chow, MD. Children's Hospital-Boston, Copyright &copy; Jeanne Chow, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_44_8898=[""].join("\n");
var outline_f8_44_8898=null;
var title_f8_44_8899="Cantharidin: Patient drug information";
var content_f8_44_8899=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Cantharidin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/57/8083?source=see_link\">",
"     see \"Cantharidin: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F145087\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Canthacur&reg;;",
"     </li>",
"     <li>",
"      Cantharone&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10014832\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691627",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to get rid of warts.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10014831\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701697",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to cantharidin or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10014836\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697169",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any blood flow problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10014837\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698333",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Short-term pain after use.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10014839\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10014834\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696363",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Your doctor will put on the skin.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10014841\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11481 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-221.10.40.232-7F6A7747C1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_44_8899=[""].join("\n");
var outline_f8_44_8899=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F145087\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014832\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014831\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014836\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014837\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014839\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014834\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014841\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?7/57/8083?source=related_link\">",
"      Cantharidin: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_44_8900="Polistes species";
var content_f8_44_8900=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F76529&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F76529&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Polistes species",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Nancy Bresich, PhD and Albert Greene, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_44_8900=[""].join("\n");
var outline_f8_44_8900=null;
var title_f8_44_8901="T1 esophageal cancer EUS";
var content_f8_44_8901=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F63620&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F63620&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    T1 esophageal cancer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 428px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopic ultrasound image showing stage T1 esophageal cancer.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of John R Saltzman, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_44_8901=[""].join("\n");
var outline_f8_44_8901=null;
var title_f8_44_8902="Chemoprevention of lung cancer";
var content_f8_44_8902=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Chemoprevention of lung cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/44/8902/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/44/8902/contributors\">",
"     Ravi Salgia, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/44/8902/contributors\">",
"     Arthur T Skarin, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/44/8902/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/44/8902/contributors\">",
"     James R Jett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/44/8902/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/44/8902/contributors\">",
"     Michael E Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/44/8902/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lung cancer is the most common cancer worldwide, with an estimated 1,600,000 new cases and 1,380,000 deaths in 2008 [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The identification of the factors responsible for lung cancer permits targeted efforts at prevention. The main risk factor is cigarette smoking, which accounts for approximately 90 percent of cases in men and an estimated 70 to 85 percent of cases in women [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/2\">",
"     2",
"    </a>",
"    ]. A variety of other environmental and occupational exposures, familial risk factors, dietary factors, and certain types of benign lung disease have also been associated with the development of lung cancer. The risk factors for lung cancer are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/0/12298?source=see_link\">",
"     \"Cigarette smoking and other risk factors for lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most important approach to lung cancer prevention is smoking cessation. However, even after people stop smoking, there is an increased risk of developing lung cancer for at least 30 to 40 years [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/3\">",
"     3",
"    </a>",
"    ]. The limitations of smoking cessation are emphasized by the fact that ex-smokers make up nearly 50 percent of all new lung cancer cases in developed countries.",
"   </p>",
"   <p>",
"    Chemoprevention can be classified as primary, secondary, or tertiary, based upon the target population:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Primary chemoprevention refers to preventing cancer in healthy individuals who are at high risk. This population primarily includes current and former smokers, as well as those with exposure to known carcinogens such as asbestos.",
"     </li>",
"     <li>",
"      Secondary chemoprevention focuses on blocking the development of cancer in individuals in whom a precancerous lesion (intraepithelial neoplasia, leukoplakia, dysplasia) has been detected.",
"     </li>",
"     <li>",
"      Tertiary chemoprevention targets patients who had a previous lung cancer in an effort to prevent the development of a second primary tumor.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Chemoprevention trials have not demonstrated a consistent benefit in preventing lung cancer or increasing survival in any of these settings, and efforts continue to identify alternative agents that are more effective.",
"   </p>",
"   <p>",
"    The rationale for and the results of large lung cancer chemoprevention trials are discussed here. Efforts to use screening to diagnose lung cancer earlier in its natural history, and thus decrease lung cancer mortality, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/58/28586?source=see_link\">",
"     \"Screening for lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     RATIONALE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chemoprevention of lung cancer is dependent upon the observation that carcinogenesis is a multi-step process that results in the stepwise accumulation of both genotypic and phenotypic aberrations [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/4\">",
"     4",
"    </a>",
"    ]. This process is manifested by a progressive dysregulation of cell growth, going from hyperplasia to metaplasia, dysplasia, carcinoma-in-situ, and invasive cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/5\">",
"     5",
"    </a>",
"    ]. The genetic mutations needed to develop an invasive cancer have not been completely elucidated.",
"   </p>",
"   <p>",
"    These changes are initiated over a large area of epithelium that is chronically exposed to large amounts of environmental carcinogens (the concept of \"field carcinogenesis\"). Within this multifocal area, cancer can develop from multiple genetically distinct clones. For lung cancer, the most common environmental carcinogen is tobacco smoke.",
"   </p>",
"   <p>",
"    Chemoprevention uses various chemical agents to prevent the progression of these changes from normal epithelium to cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/4\">",
"     4",
"    </a>",
"    ]. Phase II trials have used surrogate markers (eg, worsening dysplasia, Ki67 index) but these have not been validated as intermediate endpoints for cancer. Thus large phase III trials, using lung cancer as the endpoint, are ultimately required to assess a new chemopreventive agent.",
"   </p>",
"   <p>",
"    Epidemiologic studies have suggested that low serum concentrations of antioxidant compounds, especially derivatives of vitamins A and E, are associated with the development of lung cancer. Additional evidence supporting these compounds as chemopreventive agents was derived from studies with in vitro carcinogen-induced or animal tumor models. This combination of epidemiologic and laboratory evidence has provided the rationale for extensive clinical trials.",
"   </p>",
"   <p>",
"    Further research into the molecular pathways of lung cancer carcinogenesis has lead to the identification of other candidates for lung cancer chemoprevention. These include tyrosine kinase inhibitors that block the epidermal growth factor receptor pathways (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/13/36056?source=see_link\">",
"     erlotinib",
"    </a>",
"    ) and cyclooxygenase-2 inhibitors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PRIMARY CHEMOPREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preclinical studies and initial clinical evaluations provided a rationale for the evaluation of both alpha tocopherol and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/50/21283?source=see_link\">",
"     beta-carotene",
"    </a>",
"    for the primary prevention of lung cancer. However, four large randomized trials failed to confirm a benefit from either agent [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/6-12\">",
"     6-12",
"    </a>",
"    ], and two of the trials suggested that beta-carotene actually was associated with an increased incidence of lung cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/7,10\">",
"     7,10",
"    </a>",
"    ]. A similar increase in lung cancer risk with beta-carotene was observed in a large, observational study [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7977442\">",
"    <span class=\"h2\">",
"     ATBC Cancer Prevention Study",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the Alpha-Tocopheral,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/50/21283?source=see_link\">",
"     Beta-Carotene",
"    </a>",
"    (ATBC) Cancer Prevention Study, 29,133 male smokers in Finland were randomly assigned to alpha tocopherol, beta-carotene, both agents, or placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/6\">",
"     6",
"    </a>",
"    ]. At a median follow-up of over six years, treatment with beta-carotene was associated with an 18 percent increase in lung cancer incidence and 8 percent more deaths overall. The excess risk of lung cancer and death appeared to decline once supplements were discontinued [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/7\">",
"     7",
"    </a>",
"    ]. Treatment with alpha tocopherol appeared to have no effect on either the incidence of lung cancer or the death rate, although higher serum levels were associated with a lower risk of lung cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7977454\">",
"    <span class=\"h2\">",
"     CARET trial",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/50/21283?source=see_link\">",
"     Beta-Carotene",
"    </a>",
"    and Retinol Efficacy Trial (CARET), 18,314 smokers, former smokers, or those with extensive occupational exposure to asbestos were randomly assigned to receive a combination of daily beta-carotene and retinyl palmitate or placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/9\">",
"     9",
"    </a>",
"    ]. In the active treatment arm, there was a 28 percent higher rate of lung cancer and a 17 percent higher overall death rate. The excess rates of lung cancer and death persisted in cigarette smokers and individuals with occupational exposure to asbestos after cessation of beta-carotene and retinyl palmitate although the differences were no longer statistically significant [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7977465\">",
"    <span class=\"h2\">",
"     Physicians Health Study",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the Physicians Health Study, 22,071 male physicians (11 percent smokers, 39 percent former smokers, and 50 percent nonsmokers) were randomly assigned to receive",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/50/21283?source=see_link\">",
"     beta-carotene",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , both, or placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/11\">",
"     11",
"    </a>",
"    ]. After 12 years of supplementation with beta-carotene, there was no significant difference in cancer incidence or overall mortality. The dose of beta-carotene was lower than in the ATBC and CARET trials.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7977470\">",
"    <span class=\"h2\">",
"     Women's Health Study",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the Women's Health Study, 39,876 women aged 45 years and older were randomly assigned to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/50/21283?source=see_link\">",
"     beta-carotene",
"    </a>",
"    (50",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    or placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/12\">",
"     12",
"    </a>",
"    ]. There was no evidence of either benefit or harm in terms of the incidence of cancer in women assigned to beta-carotene.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     SECONDARY CHEMOPREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple, relatively small randomized trials have been conducted in patients with underlying premalignant changes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H118032684\">",
"    <span class=\"h2\">",
"     Retinoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;At least five randomized trials studied the impact of natural and synthetic retinoids given alone [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/14-17\">",
"     14-17",
"    </a>",
"    ] or in combination with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/50/21283?source=see_link\">",
"     beta-carotene",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/18\">",
"     18",
"    </a>",
"    ] on bronchial metaplasia seen in biopsy specimens or on atypia present in sputum cytology. These trials failed to demonstrate a statistically significant benefit from retinoid chemoprevention. Another trial did demonstrate an improvement when the molecular marker, RAR-beta expression, was studied as the trial endpoint [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H118032693\">",
"    <span class=\"h2\">",
"     Vitamin B12 plus folic acid",
"    </span>",
"    &nbsp;&mdash;&nbsp;A trial in 73 men with a history of 20 or more pack-years of smoking observed that a combination of vitamin B12 and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"     folic acid",
"    </a>",
"    reduced the incidence atypia in sputum cytology [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H118032702\">",
"    <span class=\"h2\">",
"     Anethole dithiolethione",
"    </span>",
"    &nbsp;&mdash;&nbsp;The antioxidant anethole dithiolethione (ADT) has provided some evidence of slowing the progression of neoplastic changes. In a trial of 112 current or former smokers with at least one biopsy-proven area of bronchial dysplasia, subjects were randomly assigned to ADT or to placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/21\">",
"     21",
"    </a>",
"    ]. At the end of six months of treatment, evidence of progression was significantly less frequent in patients treated with ADT (32 versus 59 percent in those receiving placebo), as assessed by histopathologic grade and nuclear morphometric index.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H118032709\">",
"    <span class=\"h2\">",
"     Prostaglandin pathway",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cyclooxygenase-2 (COX-2), an enzyme in the arachidonic acid cascade, is upregulated and overexpressed in many tumors, including lung cancer. The mechanism by which COX-2 overexpression influences the biology of NSCLC is unclear.",
"   </p>",
"   <p>",
"    The cyclooxygenase-2 (COX-2) inhibitor",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/11/40120?source=see_link\">",
"     celecoxib",
"    </a>",
"    was studied in two randomized trials in smokers, in which proliferation (Ki-67 labeling index) and COX-2 expression were used as study endpoints [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. In both studies, there appeared to be a benefit from active intervention.",
"   </p>",
"   <p>",
"    Supplementation with the oral prostacyclin analog",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/53/37716?source=see_link\">",
"     iloprost",
"    </a>",
"    has also been investigated in a randomized phase II trial in smokers or former smokers with biopsy-proven bronchial dysplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/24\">",
"     24",
"    </a>",
"    ]. Results presented at the American Thoracic Society meeting indicate that iloprost significantly improved endobronchial dysplasia at follow-up bronchoscopy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     TERTIARY CHEMOPREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple agents have been studied to prevent the development of second primary tumors. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/38/6759?source=see_link&amp;anchor=H10#H10\">",
"     \"Multiple primary lung cancers\", section on 'Screening and prevention'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7978730\">",
"    <span class=\"h2\">",
"     Selenium",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/37/13907?source=see_link\">",
"     selenium",
"    </a>",
"    to decrease the incidence of lung cancer in patients who had been treated for one primary lung cancer was initially suggested by the Nutritional Prevention of Cancer Study, in which 1312 patients with a history of basal cell or squamous cell carcinoma of the skin were randomly assigned to selenium supplements or placebo.",
"    <strong>",
"    </strong>",
"    In a secondary analysis, the incidence of lung cancer was reduced, although this difference was not statistically significant at a median follow-up of eight years [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/25,26\">",
"     25,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Based upon those results, a randomized, double-blind placebo control trial was conducted, in which 1772 patients were randomly assigned to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/37/13907?source=see_link\">",
"     selenium",
"    </a>",
"    (200",
"    <span class=\"nowrap\">",
"     micrograms/day)",
"    </span>",
"    or placebo, with treatment to continue for four years [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/27\">",
"     27",
"    </a>",
"    ]. All patients had resected stage I NSCLC and had remained disease-free for at least six months after resection.",
"   </p>",
"   <p>",
"    The trial was designed to be analyzed after 180 events (second primary lung cancers). At the planned interim analysis, there was a trend toward a lower rate of second primary lung cancer in patients given placebo compared to those given",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/37/13907?source=see_link\">",
"     selenium",
"    </a>",
"    (1.36 versus 1.91 cases per 100 patient years, p=0.15). Both the five-year progression-free survival and overall survival rates were also lower with selenium (78 versus 72 percent and 80 versus 75 percent, respectively). The trial was discontinued for futility after 84 second primary lung cancers had been diagnosed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7977700\">",
"    <span class=\"h2\">",
"     Other agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Trials to prevent the development of a second lung cancer have evaluated other agents such as retinyl palmitate,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/62/1000?source=see_link\">",
"     isotretinoin",
"    </a>",
"    , or the combination of retinyl palmitate plus N-acetylcysteine. Chemoprevention efforts in this setting have not demonstrated a statistically significant improvement in survival.",
"   </p>",
"   <p>",
"    The clinical experience with tertiary chemoprevention using such agents is illustrated by three phase III trials:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a phase III intergroup trial, 1166 patients with resected, pathologic stage I non-small cell lung cancer were randomly assigned to the retinoid",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/62/1000?source=see_link\">",
"       isotretinoin",
"      </a>",
"      or placebo for three years [",
"      <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/28\">",
"       28",
"      </a>",
"      ]. At a median follow-up of 3.5 years, there were no statistically significant differences in time to second primary tumors, recurrence rates, or mortality.",
"     </li>",
"     <li>",
"      In the EUROSCAN trial, patients with either lung cancer or head and neck cancer were randomly assigned to treatment with retinyl palmitate, N-acetylcysteine, both, or placebo for two years [",
"      <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/29\">",
"       29",
"      </a>",
"      ]. In the 2592 patients overall and among the 1023 patients with lung cancer, there were no significant differences in the incidence of second primary tumors or in overall and event-free survival.",
"     </li>",
"     <li>",
"      In another trial following resection of stage I non-small cell lung carcinoma, 307 patients were randomly assigned to daily retinyl palmitate or placebo for 12 months [",
"      <a class=\"abstract\" href=\"UTD.htm?8/44/8902/abstract/30\">",
"       30",
"      </a>",
"      ]. At a median follow up of 46 months, there were 18 second primary tumors in the treatment arm compared with 29 in the control arm. The five-year actuarial survival was not significantly improved with retinyl palmitate (62 percent versus 54 percent with placebo).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lung cancer is diagnosed in an estimated 1.2 million people per year worldwide, and 90 percent or more die of the disease. Cigarette smoking is the primary risk factor, and cessation of smoking is the most important approach to decrease the mortality associated with this disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/0/12298?source=see_link&amp;anchor=H2#H2\">",
"     \"Cigarette smoking and other risk factors for lung cancer\", section on 'Smoking'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Efforts to prevent lung cancer also have included the use of various chemical agents, particularly retinoids and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/50/21283?source=see_link\">",
"     beta-carotene",
"    </a>",
"    . These agents have been evaluated for primary chemoprevention in smokers and former smokers, for secondary chemoprevention in patients with known premalignant lesions, and for tertiary prophylaxis in patients who already have had a primary lung tumor. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Rationale'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    At least three large randomized trials have failed to demonstrate any benefit from retinoids, alpha tocopherol, or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/50/21283?source=see_link\">",
"     beta-carotene",
"    </a>",
"    for primary chemoprevention of lung cancer. Similarly, randomized trials for secondary and tertiary chemoprevention have also not demonstrated any benefit, with the exception of one trial using the antioxidant anethole dithiolethione. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Rationale'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H5\">",
"     'Primary chemoprevention'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H6\">",
"     'Secondary chemoprevention'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H7\">",
"     'Tertiary chemoprevention'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Although these trials have been disappointing, newer agents are being evaluated, particularly in the setting of secondary and tertiary prevention. Currently, the use of all such agents remains experimental.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/1\">",
"      Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/2\">",
"      Shopland DR. Tobacco use and its contribution to early cancer mortality with a special emphasis on cigarette smoking. Environ Health Perspect 1995; 103 Suppl 8:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/3\">",
"      McLaughlin JK, Hrubec Z, Blot WJ, Fraumeni JF Jr. Smoking and cancer mortality among U.S. veterans: a 26-year follow-up. Int J Cancer 1995; 60:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/4\">",
"      Sporn MB. Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res 1976; 36:2699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/5\">",
"      Salgia R, Skarin AT. Molecular abnormalities in lung cancer. J Clin Oncol 1998; 16:1207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/6\">",
"      The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 1994; 330:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/7\">",
"      Virtamo J, Pietinen P, Huttunen JK, et al. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA 2003; 290:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/8\">",
"      Woodson K, Tangrea JA, Barrett MJ, et al. Serum alpha-tocopherol and subsequent risk of lung cancer among male smokers. J Natl Cancer Inst 1999; 91:1738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/9\">",
"      Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334:1150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/10\">",
"      Goodman GE, Thornquist MD, Balmes J, et al. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. J Natl Cancer Inst 2004; 96:1743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/11\">",
"      Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334:1145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/12\">",
"      Lee IM, Cook NR, Manson JE, et al. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. J Natl Cancer Inst 1999; 91:2102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/13\">",
"      Satia JA, Littman A, Slatore CG, et al. Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study. Am J Epidemiol 2009; 169:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/14\">",
"      Kurie JM, Lee JS, Khuri FR, et al. N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium. Clin Cancer Res 2000; 6:2973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/15\">",
"      Arnold AM, Browman GP, Levine MN, et al. The effect of the synthetic retinoid etretinate on sputum cytology: results from a randomised trial. Br J Cancer 1992; 65:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/16\">",
"      Lee JS, Lippman SM, Benner SE, et al. Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. J Clin Oncol 1994; 12:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/17\">",
"      Kelly K, Kittelson J, Franklin WA, et al. A randomized phase II chemoprevention trial of 13-CIS retinoic acid with or without alpha tocopherol or observation in subjects at high risk for lung cancer. Cancer Prev Res (Phila) 2009; 2:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/18\">",
"      McLarty JW, Holiday DB, Girard WM, et al. Beta-Carotene, vitamin A, and lung cancer chemoprevention: results of an intermediate endpoint study. Am J Clin Nutr 1995; 62:1431S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/19\">",
"      Kurie JM, Lotan R, Lee JJ, et al. Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trial. J Natl Cancer Inst 2003; 95:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/20\">",
"      Heimburger DC, Alexander CB, Birch R, et al. Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. Report of a preliminary randomized, double-blind intervention trial. JAMA 1988; 259:1525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/21\">",
"      Lam S, MacAulay C, Le Riche JC, et al. A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia. J Natl Cancer Inst 2002; 94:1001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/22\">",
"      Mao JT, Fishbein MC, Adams B, et al. Celecoxib decreases Ki-67 proliferative index in active smokers. Clin Cancer Res 2006; 12:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/23\">",
"      Kim ES, Hong WK, Lee JJ, et al. Biological activity of celecoxib in the bronchial epithelium of current and former smokers. Cancer Prev Res (Phila) 2010; 3:148.",
"     </a>",
"    </li>",
"    <li>",
"     Keith, RL, Kittelson, JK, Blatchford, PJ, et al. Oral iloprost for the chemoprevention of lung cancer (Abstract). Presented at the American Thoracic Society meeting, 2010.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/25\">",
"      Clark LC, Combs GF Jr, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996; 276:1957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/26\">",
"      Reid ME, Duffield-Lillico AJ, Garland L, et al. Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial. Cancer Epidemiol Biomarkers Prev 2002; 11:1285.",
"     </a>",
"    </li>",
"    <li>",
"     Karp, DD, Lee, SJ, ShawWright, GL, et al. A phase III, intergroup, randomized, double-blind, chemoprevention trial of selenium supplementation in resected stage I non-small cell lung cancer (abstract #7004). J Clin Oncol 2010; 28:959s.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/28\">",
"      Lippman SM, Lee JJ, Karp DD, et al. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst 2001; 93:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/29\">",
"      van Zandwijk N, Dalesio O, Pastorino U, et al. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups. J Natl Cancer Inst 2000; 92:977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8902/abstract/30\">",
"      Pastorino U, Infante M, Maioli M, et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 1993; 11:1216.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4604 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-122.72.76.133-4874105216-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_44_8902=[""].join("\n");
var outline_f8_44_8902=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      RATIONALE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PRIMARY CHEMOPREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7977442\">",
"      ATBC Cancer Prevention Study",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7977454\">",
"      CARET trial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7977465\">",
"      Physicians Health Study",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7977470\">",
"      Women's Health Study",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      SECONDARY CHEMOPREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H118032684\">",
"      Retinoids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H118032693\">",
"      Vitamin B12 plus folic acid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H118032702\">",
"      Anethole dithiolethione",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H118032709\">",
"      Prostaglandin pathway",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      TERTIARY CHEMOPREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7978730\">",
"      Selenium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7977700\">",
"      Other agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/0/12298?source=related_link\">",
"      Cigarette smoking and other risk factors for lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/38/6759?source=related_link\">",
"      Multiple primary lung cancers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/58/28586?source=related_link\">",
"      Screening for lung cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_44_8903="Yolk sac tumor Low";
var content_f8_44_8903=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F78211&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F78211&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mediastinal yolk sac tumor",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 236px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Photomicrograph shows the characteristic reticular pattern of yolk sac tumors, with various sized spaces lined by flattened cells. (Hematoxylin and eosin, magnification x 50).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William Travis, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_44_8903=[""].join("\n");
var outline_f8_44_8903=null;
var title_f8_44_8904="Psychosocial interventions for schizophrenia";
var content_f8_44_8904=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Psychosocial interventions for schizophrenia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/44/8904/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/44/8904/contributors\">",
"     Juan Bustillo, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/44/8904/contributors\">",
"     Elizabeth Weil, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/44/8904/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/44/8904/contributors\">",
"     Stephen Marder, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/44/8904/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/44/8904/contributors\">",
"     Richard Hermann, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/44/8904/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 23, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H13622211\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Schizophrenia is a psychiatric disorder involving chronic or recurrent psychosis. It is commonly associated with impairments in social and occupational functioning. [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/1\">",
"     1",
"    </a>",
"    ]. It is among the most disabling and economically catastrophic medical disorders, ranked by the World Health Organization as one of the top ten illnesses contributing to the global burden of disease [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Antipsychotic medications are first-line treatment for schizophrenia. They have been shown in clinical trials to be effective in reducing symptoms and behaviors associated with the disorder. However, most patients with schizophrenia experience disabling impairment even after benefiting from antipsychotics, including positive and negative symptoms, cognitive deficits, poor social functioning, and episodes of acute symptomatic relapse. Empirically validated psychosocial interventions, added to antipsychotic medication, target one or more of these deficit areas.",
"   </p>",
"   <p>",
"    This topic addresses psychosocial interventions for schizophrenia. Psychosocial interventions for severe mental illness (not limited to schizophrenia), including assertive community treatment and supported employment, are discussed separately. The epidemiology, pathogenesis, clinical presentation, clinical manifestations, course, diagnosis and pharmacotherapy for schizophrenia are also discussed separately. Common comorbid presentations of schizophrenia are also discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/15/1270?source=see_link&amp;anchor=H1988859#H1988859\">",
"     \"Psychosocial interventions for severe mental illness\", section on 'Efficacy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/37/20057?source=see_link\">",
"     \"Schizophrenia: Epidemiology and pathogenesis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/47/34552?source=see_link\">",
"     \"Schizophrenia: Clinical manifestations, course, assessment, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/21/25944?source=see_link\">",
"     \"Depression in schizophrenia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/3/2105?source=see_link\">",
"     \"Anxiety in schizophrenia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/42/36521?source=see_link\">",
"     \"Dual diagnosis: Severe mental illness and substance use disorders\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/35/29241?source=see_link\">",
"     \"Pharmacotherapy for schizophrenia: Acute and maintenance phase treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/9/30871?source=see_link\">",
"     \"Pharmacotherapy for schizophrenia: Long-acting injectable antipsychotic drugs\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19410373\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following treatment with antipsychotic medication, which is often only partially effective, most individuals with schizophrenia would benefit from systematic rehabilitation. This may include family interventions, social skills training,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cognitive behavioral therapy, which are discussed in this topic, as well as assertive community treatment and supported employment, which are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/15/1270?source=see_link\">",
"     \"Psychosocial interventions for severe mental illness\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Psychosocial interventions are indicated for patients with schizophrenia and the characteristics that follow as an adjunct to antipsychotic medication:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Family psychoeducational intervention",
"      </strong>",
"      &mdash; For patients who have had a recent psychotic relapse and have significant ongoing contact with family members, we recommend psychoeducational intervention with the patient and family members (See",
"      <a class=\"local\" href=\"#H13622397\">",
"       'Family-based Interventions'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      <strong>",
"       Social skills training",
"      </strong>",
"      &mdash; For individuals with schizophrenia who have deficits in skills needed for everyday activities, we recommend social skills training (See",
"      <a class=\"local\" href=\"#H13622373\">",
"       'Social skills training'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      <strong>",
"       Cognitive behavioral therapy",
"      </strong>",
"      &mdash; For individuals who experience persistent delusions or hallucinations despite adequate trials of antipsychotic medication, we recommend treatment with CBT. (See",
"      <a class=\"local\" href=\"#H633970811\">",
"       'Cognitive behavioral therapy'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite evidence of their effectiveness from randomized trials, the availability of these interventions varies widely, even in developed countries, as does the availability of clinicians trained to provide them.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13622397\">",
"    <span class=\"h1\">",
"     FAMILY-BASED INTERVENTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goals of a family intervention for schizophrenia are to:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prevent relapse",
"     </li>",
"     <li>",
"      Promote medication adherence",
"     </li>",
"     <li>",
"      Promote a supportive family environment",
"     </li>",
"     <li>",
"      Reduce distress among family members",
"     </li>",
"     <li>",
"      Develop an appropriate level of patient autonomy",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13622218\">",
"    <span class=\"h2\">",
"     Theoretical foundation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The level of continuous stress between patients with schizophrenia and their environment has been found to be a robust predictor of relapse [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/3\">",
"     3",
"    </a>",
"    ]. This finding began with the study of &ldquo;expressed emotion&rdquo; (EE), an empirically developed concept characterizing families who are rated highly on hostile, critical or over-involved comments. Patients with schizophrenia who had extensive face-to-face contact with &ldquo;high EE&rdquo; family members have been found to have a higher risk of relapse, compared to patients with low-EE families, following hospitalization with effective pharmacotherapy. The relationship between high EE and relapse is not specific to schizophrenia, but has been observed in other chronic psychiatric and non-psychiatric illnesses [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13622225\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with schizophrenia who have had a recent psychotic relapse and have significant ongoing contact with family members, including relatives and significant others, we recommend the patient and family members receive a family intervention for six to nine months as augmentation to treatment with antipsychotic medication.",
"   </p>",
"   <p>",
"    For patients with schizophrenia who have experienced multiple psychotic relapses and reside in a particularly stressful family environment, a more intensive problem-solving family therapy may be helpful [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/5\">",
"     5",
"    </a>",
"    ], although the only controlled trial of the intervention was negative. (See",
"    <a class=\"local\" href=\"#H115334380\">",
"     'Administration'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H13622239\">",
"     'Efficacy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1343760\">",
"    <span class=\"h2\">",
"     Interventions",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13622232\">",
"    <span class=\"h3\">",
"     Family intervention",
"    </span>",
"    &nbsp;&mdash;&nbsp;A family intervention for schizophrenia seeks to establish a collaborative process involving the patient, family and clinician. Patients and family members receive education about the nature, course, and treatment of schizophrenia [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/5\">",
"     5",
"    </a>",
"    ], including the following objectives:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Present schizophrenia as a brain disorder with genetic, perinatal, and environmental risk factors. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/37/20057?source=see_link&amp;anchor=H31673369#H31673369\">",
"       \"Schizophrenia: Epidemiology and pathogenesis\", section on 'Pathogenesis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Correct the erroneous notion that poor parenting causes schizophrenia. Parents left to wonder, &ldquo;What could I have done wrong to have caused the illness?&rdquo;, need help proceeding from guilt and blame to acceptance and support.",
"     </li>",
"     <li>",
"      Appeal to the &ldquo;common sense&rdquo; of family members that persons with a chronic, relapsing illness tend to experience exacerbations in response to continuous stress.",
"     </li>",
"     <li>",
"      Identify and explain common manifestations of schizophrenia, such as avolition and asociality, which family members may otherwise perceive as &ldquo;laziness&rdquo;.",
"     </li>",
"     <li>",
"      Identify potential targets for further intervention (such as social skills deficits) and establish reasonable expectations for improvement. (See",
"      <a class=\"local\" href=\"#H13622373\">",
"       'Social skills training'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Explain that delusions, talking to oneself, and other dramatic manifestations of schizophrenia, which a family member might see as &ldquo;craziness&rdquo;, are, in fact, distressing symptoms of the disorder that are likely to improve with treatment. (See",
"      <a class=\"local\" href=\"#H633970811\">",
"       'Cognitive behavioral therapy'",
"      </a>",
"      below and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/35/29241?source=see_link\">",
"       \"Pharmacotherapy for schizophrenia: Acute and maintenance phase treatment\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Teach how to recognize early warning signs of relapse and develop a plan in collaboration with the patient and family members for what to do when signs become apparent.",
"     </li>",
"     <li>",
"      Explain the importance of medication adherence. Emphasize that cognitively impaired individuals may present with overt poor-compliance while patients with limited insight may have covert compliance issues.",
"     </li>",
"     <li>",
"      Provide education about the high co-morbidity of substance abuse",
"     </li>",
"     <li>",
"      Foster optimism and actively discourage the development of nihilism. Schizophrenia is a heterogeneous disorder that is not limited to a uniform outcome of progressive deterioration. For the majority of patients, integrated, comprehensive treatment, including pharmacological and psychosocial interventions, provided early in the illness can significantly improve functioning and as many as 20 percent can be expected to have a full recovery [",
"      <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/6\">",
"       6",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/47/34552?source=see_link&amp;anchor=H115334799#H115334799\">",
"       \"Schizophrenia: Clinical manifestations, course, assessment, and diagnosis\", section on 'Course'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H115334322\">",
"    <span class=\"h3\">",
"     Problem-solving family therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with multiple relapses of schizophrenia who reside in a particularly stressful family environment, a more intensive, problem-solving family therapy has been developed [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Components of this approach include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Identify critical, hostile, and over-involved parent-patient interactions, explaining that these interactions are associated with worse outcomes, but taking care to avoid misunderstandings that they are a cause of the disorder.",
"     </li>",
"     <li>",
"      Help families and patients to avoid adverse interactions. An example is re-framing a family member&rsquo;s critical assessment of a patient who will not clean up after him or herself, from &ldquo;passivity&rdquo; or &ldquo;laziness&rdquo; to &ldquo;avolition&rdquo; (ie, a lack of motivation for goal directed behavior), a common symptom of schizophrenia.",
"     </li>",
"     <li>",
"      Assign &ldquo;homework&rdquo;, for example, to encourage the patient to implement simple tasks, while encouraging parents to refrain from being critical or prematurely involved.",
"     </li>",
"     <li>",
"      Stressful family dynamics can often be best addressed by finding outside rehabilitative activities or supported employment for the patient. (See",
"      <a class=\"local\" href=\"#H13622373\">",
"       'Social skills training'",
"      </a>",
"      below and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/15/1270?source=see_link&amp;anchor=H1988831#H1988831\">",
"       \"Psychosocial interventions for severe mental illness\", section on 'Supported employment'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      An isolated and distressed parent can be encouraged to develop hobbies outside of the house without concern that",
"      <span class=\"nowrap\">",
"       he/she",
"      </span>",
"      needs to be monitoring the patient at home. This can support the development of a schedule for training for the patient in more independent living skills. A minority of patients who need constant supervision due to safety issues may require attendance at a specialized daycare program.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H115334380\">",
"    <span class=\"h2\">",
"     Administration",
"    </span>",
"    &nbsp;&mdash;&nbsp;A family psychosocial intervention for schizophrenia is typically provided in monthly sessions, which should be continued for six to nine months [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/9\">",
"     9",
"    </a>",
"    ]. These sessions may be for an individual family or for groups of families. They should be in addition to the patient&rsquo;s individual visits with a psychiatrist and other clinicians.",
"   </p>",
"   <p>",
"    Problem-solving therapy is usually more intensive than a typical family intervention, requiring weekly or bi-weekly visits for the initial two to three months, sometimes in the home [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/5\">",
"     5",
"    </a>",
"    ]. After this period, typically, a monthly schedule of more supportive maintenance sessions can be adopted.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13622239\">",
"    <span class=\"h2\">",
"     Efficacy",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1343211\">",
"    <span class=\"h3\">",
"     Family intervention",
"    </span>",
"    &nbsp;&mdash;&nbsp;A meta-analysis of 2981 individuals with schizophrenia or schizoaffective disorder in 32 randomized trials found that a family intervention of at least five sessions reduced the frequency of relapse compared to a control condition (Relative Risk [RR] = 0.55, CI 0.5 to 0.6; number need to treat = 7) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/10\">",
"     10",
"    </a>",
"    ]. Reductions were also seen in hospital admissions and medication non-adherence. There is less support from clinical trials for shorter family interventions and family interventions for stable individuals who had not had a recent exacerbation of illness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1343301\">",
"    <span class=\"h3\">",
"     Problem-solving family therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the largest randomized trial of problem-solving family therapy, 313 patients were assigned to one of three antipsychotic dosing strategies and either a problem-solving family therapy or a monthly family psychoeducational group [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/5\">",
"     5",
"    </a>",
"    ]. No differences were seen between groups receiving the two family interventions. In our clinical experience, we have found that problem-solving family therapy prevents re-hospitalization in patients with multiple relapses of schizophrenia who reside in a particularly stressful family environment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13622373\">",
"    <span class=\"h1\">",
"     SOCIAL SKILLS TRAINING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deficits in areas such as social interactions and independent living skills often interfere with the ability of people with schizophrenia to perform everyday activities and to function in the community. As examples, individuals may have difficulties with personal care, cooking, laundry, paying bills, use of public transportation, leisure activities, developing social networks, and dating.",
"   </p>",
"   <p>",
"    Deficits in these skills are related to the negative symptoms (or &ldquo;deficit symptoms&rdquo;) of schizophrenia. Negative symptoms rarely respond to pharmacotherapy alone [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/11\">",
"     11",
"    </a>",
"    ], but have been found to respond to social skills training as augmentation of antipsychotic medications [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Social skills training for individuals with schizophrenia consists of behavioral training focused on specific situations, problems, and activities. The ultimate goal of this training is the generalization of learned skills to community-based activities with improved functioning.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13622302\">",
"    <span class=\"h2\">",
"     Theoretical foundation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two programs stemming from distinct conceptual models have been developed to address social skills deficits of people with schizophrenia, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basic social skills training utilizes principles from learning theory to improve social functioning by working with patients to remediate problems in activities of daily living, leisure, relationships, or employment [",
"      <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The social problem-solving model focuses on improving impairments in information processing that are assumed to be the cause of deficits in social skills [",
"      <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13622309\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend that individuals with schizophrenia who have deficits in skills needed for everyday activities receive social skills training. If there is a choice among social skills training models available, a reasonable approach is to start with the basic model, and if the patient does not experience an adequate response, advance to the more complex problem-solving intervention. Selection may be constrained by the local availability of only one model.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13622316\">",
"    <span class=\"h2\">",
"     Intervention",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two forms of social skills training: the basic model and the social problem-solving model. Although the field has evolved to more integrated, manualized, step-by-step guides [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/15\">",
"     15",
"    </a>",
"    ], we briefly describe both models to illustrate the evolution of this therapeutic approach.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3203416\">",
"    <span class=\"h3\">",
"     Basic model",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the basic model, complex social repertoires (such as conversation with a peer) are broken down into simpler steps, which can be taught more effectively, practiced in role playing exercises, and applied in natural settings.",
"   </p>",
"   <p>",
"    While the content of skills training programs may vary with the program or with the needs of individual patients, most include an emphasis on interpersonal skills [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/13\">",
"     13",
"    </a>",
"    ]. Basic training techniques include behaviorally based instruction, role modeling, rehearsal, corrective feedback, and positive reinforcement. Typical steps include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Initial training may start with conversation between therapist and patient with immediate feedback to the patient on specific, problematic interpersonal behaviors.",
"     </li>",
"     <li>",
"      The conversation may be videotaped; the therapist would then review the tape with the patient, pointing out problematic behaviors and suggesting desired alternatives.",
"     </li>",
"     <li>",
"      After several sessions with the same therapist, the patient may be encouraged to interact with other staff and patients.",
"     </li>",
"     <li>",
"      Eventually these skills may be practiced in the patient&rsquo;s own environment to implement the learned skills more generally. Programs that start as clinic-based can be adapted to targeted areas such as the patient&rsquo;s work place and social settings.",
"     </li>",
"     <li>",
"      As examples:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A person with affective flattening, poverty of speech, and poor social interaction is encouraged to role play with the therapist. They start a conversation and the therapist provides feedback to foster increased eye-contact, and appropriate hand gesticulation, nodding, and asking follow-up questions.",
"     </li>",
"     <li>",
"      A paranoid person, with intense responses to others and intimidating eye contact, is encouraged to look down at times, pause before responding, and lower",
"      <span class=\"nowrap\">",
"       his/her",
"      </span>",
"      voice.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3203426\">",
"    <span class=\"h3\">",
"     Social problem solving model",
"    </span>",
"    &nbsp;&mdash;&nbsp;The social problem-solving model targets behavioral or symptom domains needing changes. The module is based on a conceptualization of social problems in patients with schizophrenia as based, in part, on deficits in receiving, processing and sending skills [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/14\">",
"     14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Receiving skills refer to those necessary to appropriately identify social cues.",
"     </li>",
"     <li>",
"      Processing skills deal with the context-appropriate interpretation of information and the generation of the various potential responses.",
"     </li>",
"     <li>",
"      Sending skills correspond to the behaviors targeted by the basic skills model.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The patient is evaluated for problem behaviors and if present the patient is assigned to a relevant module addressing an area for improvement, including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Medication and symptom management",
"     </li>",
"     <li>",
"      Recreational activities",
"     </li>",
"     <li>",
"      Basic conversation",
"     </li>",
"     <li>",
"      Self-care",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In each module, an emphasis is placed on learning receiving, processing and sending skills. Each module is taught, typically in a classroom setting. (See",
"    <a class=\"local\" href=\"#H3203510\">",
"     'Administration'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3203510\">",
"    <span class=\"h2\">",
"     Administration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Social skills training is generally conducted several times a week (either in training sessions or as patient practice) for three to six months. After the completion of the program, &ldquo;booster&rdquo; sessions are used in order to maintain gains and facilitate further generalization. Social skills training can be administered as monotherapy or in combination with cognitive psychotherapeutic approaches in the context of cognitive remediation or CBT [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinicians typically need specific training to effectively deliver social-skills training to patients. However, the availability of training manuals, instructional videos, and patient workbooks can aid the implementation of these programs in various community settings [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13622323\">",
"    <span class=\"h2\">",
"     Efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A meta-analysis of 22 randomized trials found that social skills training (irrespective of the model) was an effective treatment for individuals with schizophrenia compared to other interventions or treatment as usual, showing a large effect size of 1.2 for content mastery (95 percent CI: 0.96 to 1.43) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/12\">",
"     12",
"    </a>",
"    ]. Analyses of trials that included the measures found that social skills training led to improvement in interpersonal and everyday life skills (a moderate effect size of 0.52; 95 percent CI: 0.34 to 0.71), community functioning, and negative symptoms. Evidence is weak or mixed in support of social skills training for other symptoms of schizophrenia, including relapse. There are no trials comparing the effectiveness of different models of social skills training.",
"   </p>",
"   <p>",
"    A systematic review found evidence of skills retention for up to one year following training; more studies for longer periods are needed [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/9\">",
"     9",
"    </a>",
"    ]. Generalization of social skills to the patient&rsquo;s environment is most effective when the training is practiced in that environment. Programs that include the practice of trained skills in the community are more effective than those that are exclusively clinic based, relying on homework assignments for generalization.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1343443\">",
"    <span class=\"h1\">",
"     COGNITIVE REMEDIATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cognitive remediation attempts to improve the learning process by targeting more fundamental cognitive impairments, such as attention or planning. The assumption is that if the underlying cognitive impairment can be improved initially, this learning will support more complex cognitive processes, and the patient can then benefit from social skills training, generalizing from its lessons to improve interactions in the community.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1343457\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend that individuals with schizophrenia who experience persistent subjective cognitive deficits (difficulty concentrating or remembering) coupled with scholastic",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    vocational difficulties receive cognitive remediation as an adjunct to antipsychotic medication.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19490983\">",
"    <span class=\"h2\">",
"     Administration",
"    </span>",
"    &nbsp;&mdash;&nbsp;This approach begins with having the patient repeatedly practice a simple information processing task on a computer, such as speed of response to various stimuli to improve vigilance [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Once the person reaches a specified performance threshold, he or she will move on to a more complex computer-based task, such as a test of working memory. Eventually, other higher-order tasks as such planning and social recognition are addressed. Posit Science is a self-contained computer software program for providing cognitive remediation in an outpatient treatment setting or to be used by a patient at home [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Once these cognitive skills have improved to an adequate level, the person participates in one of the more traditional social-skills training approaches, such as the basic model or the social problem-solving model. (See",
"    <a class=\"local\" href=\"#H13622373\">",
"     'Social skills training'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19491036\">",
"    <span class=\"h2\">",
"     Efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A meta-analysis of 2,104 participants from 40 clinical trials (each of which studied samples comprised of at least 70 percent patients with schizophrenia, and otherwise patients with other serious mental illnesses) found cognitive remediation for persons with schizophrenia led to an overall moderate, positive effect with an effect size of 0.45 (95% confidence interval [CI]=0.31&mdash;0.59). Analyses of trials including these measures found moderate improvements in global cognition (effect size of 0.45; CI 0.31-0.59) and functioning (effect size of 0.37; CI 0.11-0.635) compared to other interventions or to a passive control condition [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/17\">",
"     17",
"    </a>",
"    ]. Interventions that integrated cognitive remediation with treatment based on the social problem-solving model have shown evidence of efficacy with some evidence for generalization to community settings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H633970811\">",
"    <span class=\"h1\">",
"     COGNITIVE BEHAVIORAL THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cognitive behavioral therapy (CBT) for schizophrenia combines cognitive approaches with social skills training, a behavioral intervention. (See",
"    <a class=\"local\" href=\"#H13622373\">",
"     'Social skills training'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    CBT is used to treat medication-resistant psychosis in patients with schizophrenia. Its principal aims are to reduce the intensity of delusions and hallucinations (and related distress) and to promote active participation of the individuals in reducing their risk of relapse and their social disability. Other target symptoms of CBT include the patient&rsquo;s preoccupation with the delusions and hallucinations, and the impact of symptoms on his or her behavior.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H633970894\">",
"    <span class=\"h2\">",
"     Theoretical foundation",
"    </span>",
"    &nbsp;&mdash;&nbsp;CBT for schizophrenia presumes that a patient with the disorder can, with the help of a therapist, engage in a logical examination of maladaptive aspects of their symptoms. Despite active psychosis, most patients with schizophrenia have the verbal and cognitive capacities to participate in CBT. CBT begins with the patient&rsquo;s interpretation of symptoms, from which the patient and therapist work collaboratively to develop more rational and adaptive behaviors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H633970901\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;People with schizophrenia often have some degree of persistent psychosis even when pharmacotherapy has been optimized. We recommend that patients who experience persistent delusions or hallucinations despite adequate trials of antipsychotic medication receive adjunctive CBT. Adequate trials of antipsychotics include use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/21/35161?source=see_link\">",
"     clozapine",
"    </a>",
"    for treatment resistant psychosis, though some patients refuse clozapine due to the risk of agranulocytosis or the inconvenience of repeated blood tests for monitoring. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/40/6793?source=see_link\">",
"     \"Guidelines for prescribing clozapine in schizophrenia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/10/15530?source=see_link&amp;anchor=H76524735#H76524735\">",
"     \"Second-generation antipsychotic medications: Pharmacology, administration, and comparative side effects\", section on 'Clozapine'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H633970908\">",
"    <span class=\"h2\">",
"     Cognitive approaches",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cognitive approaches to patients with schizophrenia focus on exploring the subjective nature of their symptoms, gently challenging their underlying assumptions, and generating alternative interpretations [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The experience and meaning of the beliefs and percepts is initially explored, with the aim of constructing a model of events that makes sense to the individual based on his or her own personal history and perspective. This initial framework allows the therapist to know the language and context the individual uses to describe his symptoms.",
"   </p>",
"   <p>",
"    Focused work can then begin on specific delusions and hallucinations by identifying them and collaboratively reviewing with the patient the presence or absence of evidence supporting their validity. This reality testing is followed by generating alternative responses to the delusions or hallucinations. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A patient who reports hearing a derogatory voice telling her that she is worthless can be encouraged to look to see if someone is speaking, or to ask a companion if they hear anything. The patient and clinician then review the findings. Based on the absence of supportive evidence, they can then develop alternative interpretations of the voice, such as that the patient may have misinterpreted an inner experience or misattributed the sensation to an outside source.",
"     </li>",
"     <li>",
"      A patient with a delusional belief that he has a device implanted in his body, which is sending signals externally, can be encouraged to evaluate evidence for and against the possibility of its existence. As examples, the clinician might ask:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      When was the device implanted?",
"     </li>",
"     <li>",
"      Where were you at that time? Were you taken to a hospital with surgical facilities?",
"     </li>",
"     <li>",
"      Was your family living with you? How could they have missed you being gone for that long?",
"     </li>",
"     <li>",
"      Where was the device implanted? Can you show me a scar on the overlying skin?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the absence of supporting evidence, the clinician and patient would generate alternative explanations for the symptoms, such as the patient&rsquo;s misinterpretation of a somatic sensation in the area of the implant or a strong emotion.",
"   </p>",
"   <p>",
"    Patients who strongly resist reevaluating delusional beliefs can nevertheless be encouraged to identify ways to reduce related distress while continuing to hold the belief. In the prior example, this may involve learning to live with an implanted device or learning to control its signaling.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H633970915\">",
"    <span class=\"h2\">",
"     Administration",
"    </span>",
"    &nbsp;&mdash;&nbsp;CBT can be provided in either an individual or group format. The frequency and duration of therapy can vary but typically consists of weekly or biweekly sessions for four to nine months. Patients who are able to reframe the delusions and hallucinations and develop some psychological distance from these experiences can then be seen less frequently using a more supportive psychotherapeutic approach.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H633970922\">",
"    <span class=\"h2\">",
"     Efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A meta-analysis of randomized trials found CBT to be effective in patients with persistent psychotic symptoms of schizophrenia for positive and negative symptoms, and functioning, compared to patients assigned to a control condition [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/20\">",
"     20",
"    </a>",
"    ]. The strongest effects have been seen for delusions, with successively smaller effects for hallucinations, negative symptoms, and functioning.",
"   </p>",
"   <p>",
"    As an example, a randomized trial (which was included in the meta-analysis and had typical results) of 144 patients with schizophrenia who exhibited prodromal or early signs of relapse, found CBT plus treatment as usual to lead to lower rates of hospitalization (15.3 versus 26.4 percent) and relapse (18.1 versus 34.7 percent) than treatment as usual alone after 12 months [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/21\">",
"     21",
"    </a>",
"    ]. The CBT group showed greater improvement than the control group in positive symptoms, negative symptoms, global psychopathology, performance of independent functions and prosocial activities.",
"   </p>",
"   <p>",
"    CBT has largely been shown to be effective for stable (non-acute), long-standing schizophrenia [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/9\">",
"     9",
"    </a>",
"    ]. Benefit has not been established for patients with recent onset schizophrenia or those experiencing an acute exacerbation of psychotic symptoms. A meta-analysis of clinical trials comparing CBT to other psychosocial interventions for people with schizophrenia did not show significant differences in outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13622358\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Family-based interventions, cognitive behavioral therapy, and social-skills training are used to augment antipsychotic medication in the treatment of schizophrenia. Other psychosocial interventions used for schizophrenia and other severe mental illnesses include assertive community treatment and supported employment, which are described separately. (See",
"      <a class=\"local\" href=\"#H19410373\">",
"       'Overview'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/15/1270?source=see_link\">",
"       \"Psychosocial interventions for severe mental illness\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For individuals with schizophrenia who have had a recent psychotic relapse, have significant ongoing contact with family members and have not previously received the intervention, we recommend that the patient and family members receive a family psychoeducational intervention (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). The intervention is typically provided in monthly sessions with an individual family or a group of families for six to nine months as augmentation to antipsychotic medication and other treatment. (See",
"      <a class=\"local\" href=\"#H13622397\">",
"       'Family-based Interventions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For individuals with schizophrenia who have experienced multiple psychotic relapses, and reside in a particularly stressful family environment, we suggest treatment with a more intensive problem-solving family therapy over other family psychoeducational interventions (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H115334322\">",
"       'Problem-solving family therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For individuals who experience persistent delusions or hallucinations despite adequate trials of antipsychotic medication, we recommend adjunctive treatment with cognitive behavioral therapy over medication alone (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H633970811\">",
"       'Cognitive behavioral therapy'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      Adequate trials of antipsychotics include use of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/21/35161?source=see_link\">",
"       clozapine",
"      </a>",
"      for treatment resistant psychosis in patients willing to take the medication and undergo repeated blood testing. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/40/6793?source=see_link\">",
"       \"Guidelines for prescribing clozapine in schizophrenia\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/35/29241?source=see_link&amp;anchor=H108920615#H108920615\">",
"       \"Pharmacotherapy for schizophrenia: Acute and maintenance phase treatment\", section on 'Clozapine'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For individuals with schizophrenia who have deficits in skills needed for everyday activities, we recommend social skills training as an adjunct to antipsychotic medication over medication alone (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Social skills training is generally conducted several times a week (either in training sessions with a clinician or in patient practice sessions) for three to six months. Manuals and other materials are available to support training and provision [",
"      <a class=\"abstract\" href=\"UTD.htm?8/44/8904/abstract/15\">",
"       15",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H13622373\">",
"       'Social skills training'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For individuals with schizophrenia who experience persistent subjective cognitive deficits (difficulty concentrating or remembering) coupled with scholastic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      vocational difficulties, we recommend cognitive remediation (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ) as an adjunct to antipsychotic medication over medication alone.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR), American Psychiatric Association, Washington, DC 2000.",
"    </li>",
"    <li>",
"     Murray CJL, Lopez AD. The Global Burden of Disease, Harvard University Press, Cambridge, MA 1996. p.21.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8904/abstract/3\">",
"      Butzlaff RL, Hooley JM. Expressed emotion and psychiatric relapse: a meta-analysis. Arch Gen Psychiatry 1998; 55:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8904/abstract/4\">",
"      Wood BL, Miller BD, Lim J, et al. Family relational factors in pediatric depression and asthma: pathways of effect. J Am Acad Child Adolesc Psychiatry 2006; 45:1494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8904/abstract/5\">",
"      Schooler NR, Keith SJ, Severe JB, et al. Relapse and rehospitalization during maintenance treatment of schizophrenia. The effects of dose reduction and family treatment. Arch Gen Psychiatry 1997; 54:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8904/abstract/6\">",
"      &Aacute;lvarez-Jim&eacute;nez M, Gleeson JF, Henry LP, et al. Road to full recovery: longitudinal relationship between symptomatic remission and psychosocial recovery in first-episode psychosis over 7.5 years. Psychol Med 2012; 42:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8904/abstract/7\">",
"      Falloon IR, Boyd JL, McGill CW, et al. Family management in the prevention of exacerbations of schizophrenia: a controlled study. N Engl J Med 1982; 306:1437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8904/abstract/8\">",
"      Falloon IR, Boyd JL, McGill CW, et al. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two-year longitudinal study. Arch Gen Psychiatry 1985; 42:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8904/abstract/9\">",
"      Dixon LB, Dickerson F, Bellack AS, et al. The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull 2010; 36:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8904/abstract/10\">",
"      Pharoah F, Mari J, Rathbone J, Wong W. Family intervention for schizophrenia. Cochrane Database Syst Rev 2010; :CD000088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8904/abstract/11\">",
"      Buchanan RW, Javitt DC, Marder SR, et al. The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments. Am J Psychiatry 2007; 164:1593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8904/abstract/12\">",
"      Kurtz MM, Mueser KT. A meta-analysis of controlled research on social skills training for schizophrenia. J Consult Clin Psychol 2008; 76:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8904/abstract/13\">",
"      Bellack AS, Mueser KT. Psychosocial treatment for schizophrenia. Schizophr Bull 1993; 19:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8904/abstract/14\">",
"      Eckman TA, Wirshing WC, Marder SR, et al. Technique for training schizophrenic patients in illness self-management: a controlled trial. Am J Psychiatry 1992; 149:1549.",
"     </a>",
"    </li>",
"    <li>",
"     Bellack AS, Mueser K, Gingerich S, Agresta J. Social Skills Training for Schizophenia: A step-by step guide, 2nd ed., The Guilford Press, New York 2004.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8904/abstract/16\">",
"      Vinogradov S, Fisher M, de Villers-Sidani E. Cognitive training for impaired neural systems in neuropsychiatric illness. Neuropsychopharmacology 2012; 37:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8904/abstract/17\">",
"      Wykes T, Huddy V, Cellard C, et al. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry 2011; 168:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8904/abstract/18\">",
"      Fisher M, Holland C, Merzenich MM, Vinogradov S. Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. Am J Psychiatry 2009; 166:805.",
"     </a>",
"    </li>",
"    <li>",
"     Kingdon DG, Turkington D. Cognitive-Behavioral Therapy of Schizophrenia, Guilford Publications, New York 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8904/abstract/20\">",
"      Wykes T, Steel C, Everitt B, Tarrier N. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull 2008; 34:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8904/abstract/21\">",
"      Gumley A, O'Grady M, McNay L, et al. Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy. Psychol Med 2003; 33:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8904/abstract/22\">",
"      Jones C, Hacker D, Cormac I, et al. Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia. Cochrane Database Syst Rev 2012; 4:CD008712.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15774 Version 1.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-210.101.131.232-B327878308-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_44_8904=[""].join("\n");
var outline_f8_44_8904=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13622358\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13622211\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19410373\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13622397\">",
"      FAMILY-BASED INTERVENTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13622218\">",
"      Theoretical foundation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13622225\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1343760\">",
"      Interventions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13622232\">",
"      - Family intervention",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H115334322\">",
"      - Problem-solving family therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H115334380\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13622239\">",
"      Efficacy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1343211\">",
"      - Family intervention",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1343301\">",
"      - Problem-solving family therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13622373\">",
"      SOCIAL SKILLS TRAINING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13622302\">",
"      Theoretical foundation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13622309\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13622316\">",
"      Intervention",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3203416\">",
"      - Basic model",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3203426\">",
"      - Social problem solving model",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3203510\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13622323\">",
"      Efficacy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1343443\">",
"      COGNITIVE REMEDIATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1343457\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19490983\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19491036\">",
"      Efficacy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H633970811\">",
"      COGNITIVE BEHAVIORAL THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H633970894\">",
"      Theoretical foundation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H633970901\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H633970908\">",
"      Cognitive approaches",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H633970915\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H633970922\">",
"      Efficacy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13622358\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/3/2105?source=related_link\">",
"      Anxiety in schizophrenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/21/25944?source=related_link\">",
"      Depression in schizophrenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/42/36521?source=related_link\">",
"      Dual diagnosis: Severe mental illness and substance use disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/40/6793?source=related_link\">",
"      Guidelines for prescribing clozapine in schizophrenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/35/29241?source=related_link\">",
"      Pharmacotherapy for schizophrenia: Acute and maintenance phase treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/9/30871?source=related_link\">",
"      Pharmacotherapy for schizophrenia: Long-acting injectable antipsychotic drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/15/1270?source=related_link\">",
"      Psychosocial interventions for severe mental illness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/47/34552?source=related_link\">",
"      Schizophrenia: Clinical manifestations, course, assessment, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/37/20057?source=related_link\">",
"      Schizophrenia: Epidemiology and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/10/15530?source=related_link\">",
"      Second-generation antipsychotic medications: Pharmacology, administration, and comparative side effects",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_44_8905="Tubular carcinoma of the breast";
var content_f8_44_8905=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F50273&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F50273&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 609px\">",
"   <div class=\"ttl\">",
"    Tubular carcinoma of the breast",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 589px; height: 238px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (Panel A) Low power view of a tubular breast carcinoma shows that the tumor is composed of well formed glands or tubules that invade the mammary stroma.",
"    <br/>",
"    (Panel B) High power view demonstrates that the tubules are composed of columnar cells with relatively uniform nuclei. Many of the cells show \"snouts\" of eosinophilic cytoplasm at their lumenal ends.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Stuart Schnitt, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_44_8905=[""].join("\n");
var outline_f8_44_8905=null;
var title_f8_44_8906="Overview of upper extremity peripheral nerve syndromes";
var content_f8_44_8906=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of upper extremity peripheral nerve syndromes",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/44/8906/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/44/8906/contributors\">",
"     Seward B Rutkove, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/44/8906/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/44/8906/contributors\">",
"     Jeremy M Shefner, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?8/44/8906/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?8/44/8906/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?8/44/8906/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peripheral nerve damage affecting the upper extremities can vary widely in cause and extent. Many disorders, ranging from mild carpal tunnel syndrome to severe brachial plexopathy, need to be considered in a patient presenting with pain, sensory loss, or weakness involving the shoulder, arm, or hand. Peripheral nerve syndromes involving the lower extremities are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42233?source=see_link\">",
"     \"Overview of lower extremity peripheral nerve syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nerve roots emerge from the spinal cord from the C2 level and below, each exiting through its own individual foramen. The C2-C4 roots merge close to the spinal column into a conglomeration known as the cervical plexus. Nerves emerging from this group include the phrenic and greater auricular. Although generally uninvolved in neurologic disease, lesions can occasionally affect this region and cause head extensor weakness or diaphragm paralysis.",
"   </p>",
"   <p>",
"    The C5 through T1 roots also emerge from the spinal column and give off small branches proximally that contribute to form the long thoracic nerve, which innervates the serratus anterior muscle. The roots then merge in a complex region known as the brachial plexus. A number of regions within the plexus have been defined by anatomists, including trunks, divisions, cords, branches, and proximal nerve; however, for practical purposes an understanding of the individual trunks, cords, and nerves is all that is necessary to correctly classify a problem affecting this region (",
"    <a class=\"graphic graphic_figure graphicRef50576 \" href=\"UTD.htm?34/25/35222\">",
"     figure 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The C5 and C6 roots merge to form the upper trunk; the C7 root alone makes up the middle trunk; the C8 and T1 roots form the lower trunk.",
"     </li>",
"     <li>",
"      The upper trunk becomes the lateral cord after giving off branches that contribute to the posterior cord; the lower trunk becomes the medial cord after giving off branches that contribute to the posterior cord; the middle trunk becomes the posterior cord after giving off branches which join both the upper and lower trunks.",
"     </li>",
"     <li>",
"      A number of nerves emerge from the lateral region of the plexus, including, from proximal to distal, the dorsal scapular nerve, the suprascapular nerve, the musculocutaneous nerve, and, in part, the median nerve. The ulnar nerve is the major nerve from the medial region of the plexus, while the posterior cord gives off a number of significant nerves including the axillary, subscapular, thoracodorsal, and most importantly, the radial nerve.",
"     </li>",
"     <li>",
"      As the major nerves descend down the arm, the radial and median give off two important branches, the posterior and anterior interosseous nerves, respectively. All of the nerves give off multiple branches even more distally, although most are not clinically relevant except in very specific situations. These smaller branches will be discussed where clinically distinct syndromes exist.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of different processes may affect normal nerve function in a focal fashion, as compared to a disorder such as polyneuropathy in which more diffuse neuronal dysfunction occurs. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/12/7369?source=see_link\">",
"     \"Overview of polyneuropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Compression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Compression of nerve segments (including neurapraxia and axonotmesis) is the most common problem that affects neuronal structures in the upper extremity. Compression can affect distal nerve segments as in carpal tunnel syndrome, but may also occur very proximally at the root level (eg, when a herniated cervical disc compresses the spinal root).",
"   </p>",
"   <p>",
"    The pathologic processes at any site of entrapment are relatively similar. A degree of direct compression against the nerve with associated nerve ischemia plays a role.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In its most mild form the problem may be intermittent due to positioning; a common situation is that of paresthesias in the hand in a patient with carpal tunnel syndrome when the wrist is flexed, most likely secondary to temporary nerve ischemia.",
"     </li>",
"     <li>",
"      Demyelination occurs as compression becomes more consistent and chronic. Symptoms are usually persistent at this point, although often are worsened with certain movement or positions. Pain and weakness, generally minimally noticeable early on, now may become more prominent.",
"     </li>",
"     <li>",
"      Distal nerve segments will no longer function as compression progresses and Wallerian degeneration may occur. In severe cases the entire distal segment of nerve can degenerate, similar to what would be seen in a nerve transection (see",
"      <a class=\"local\" href=\"#H6\">",
"       'Transection'",
"      </a>",
"      below).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    From a physiologic standpoint, the patient will remain asymptomatic as long as all nerve impulses are transmitted through a region of compression. As ischemia or demyelination occurs, nerve conduction will first be slowed, and then eventually blocked completely. Slowing of nerve conduction has minimal physiological correlate; only the complete conduction block of neuronal impulses produces substantial functional sensory loss or weakness. Conduction block of more and more nerve fibers occurs as compression worsens. Eventually almost no impulses make it through the compressed area, while distal neuronal degeneration simultaneously begins to take place.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Transection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute nerve transection (neurotmesis) is much less common than chronic nerve compression. It can occur with severe trauma to the arm (eg, a knife wound) as the distal nerve is completely separated from the proximal portion. Unlike even severe cases of nerve compression, the basement membrane of each individual nerve cell no longer remains intact following transection; without intervention (ie, surgical reattachment), regrowth of the nerve is impossible. Complete loss of sensory and motor responses occurs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Nerve ischemia/infarct",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nerve infarction typically only occurs with vasculitis and atherosclerotic disease. Nerve infarction in patients with vasculitis causes an axonal injury pattern, typically at specific regions. Certain nerves tend to be most affected in the upper extremity: the median nerve in the upper arm and ulnar nerve just proximal to the elbow segment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/57/22423?source=see_link\">",
"     \"Clinical manifestations of vasculitic neuropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Unlike the case of compressive neuropathy, conduction velocity slowing does not occur. The entire distal segment of the nerve degenerates within a few days of focal nerve infarction. However, since the basement membrane remains intact, regrowth of the nerve may occur with control of the underlying disease. Severe atherosclerotic disease can occasionally produce similar findings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Radiation-induced injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiation exposure, generally in the context of radiotherapy for neoplastic disease, can result in nerve damage that may not appear clinically for years after the procedure. A common situation occurs in women who have undergone axillary radiation therapy for breast cancer; progressive weakness and sensory loss with marked proprioceptive dysfunction may occur after a period of several years. Distinguishing this disorder from malignancy recurrence is usually straightforward. Nevertheless, this disorder can lead to very serious and irreversible disability.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Inflammation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inflammatory processes of the nerve or roots also can cause significant problems affecting the arm. Infectious disorders such as herpes simplex, Epstein-Barr virus, and, most commonly herpes zoster virus, can produce syndromes of sensory loss and motor dysfunction. An idiopathic inflammatory response is also responsible for the syndrome of brachial neuritis (neuralgic amyotrophy).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Degeneration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Focal degeneration of neurons may occur in certain disorders. Most concerning is a focal form of motor neuron cell loss associated with progressive weakness of an entire extremity over a period of months. Although isolated to only a single extremity, this disorder, known as monomelic amyotrophy, may actually be an early manifestation of amyotrophic lateral sclerosis. Only time determines whether a systemic process is occurring or whether the problem will remain localized to one limb.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Metabolic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Metabolic problems generally do not produce focal nerve lesions, except indirectly as can occur in patients with diabetes mellitus or hypothyroidism. Compression neuropathies (such as carpal tunnel syndrome) are much more common in these disorders for unclear reasons.",
"   </p>",
"   <p>",
"    Occasionally, diabetes mellitus has also been associated with a vasculitic-like picture (diabetic mononeuropathy multiplex). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/34/16934?source=see_link\">",
"     \"Epidemiology and classification of diabetic neuropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H491173463\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Carpal tunnel syndrome is the most common mononeuropathy, although the prevalence varies with the population studied. In one population-based study in the Netherlands, clinical carpal tunnel syndrome was present in 3.4 percent of all people, and was likely present, although undiagnosed, in an additional 5.8 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/1\">",
"     1",
"    </a>",
"    ]. The disorder was much more common in women; the overall prevalence was only 0.6 percent in men. In another study from the Mayo Clinic, the annual incidence rate was only 99 per 100,000 (0.1 percent) with a female to male ratio of 3:1 [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cervical radiculopathy is also common. At the Mayo clinic, the average incidence of this disorder between 1976 and 1990 was 83 per 100,000, with higher rates in men than in women [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/3\">",
"     3",
"    </a>",
"    ]. The incidence was highest in people 50 to 54 years of age, with C6 and C7 root lesions making up 64 percent of all cases.",
"   </p>",
"   <p>",
"    The incidence of brachial plexitis has also been studied through the Mayo Clinic records. Over a 12-year period, the annual incidence of this disorder was only 1.6 per 100,000 population [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is likely that these numbers are underestimations of the true incidence. Mild cases of radiculopathy or brachial neuritis may never reach medical attention or may be misdiagnosed as a musculoskeletal injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The signs and symptoms suggestive of a peripheral nerve problem are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/32/8712?source=see_link\">",
"     \"Differential diagnosis of peripheral nerve and muscle disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Very mild focal abnormalities of the upper extremity nerves may be identified when performing electrophysiologic testing for other reasons (eg, to look for polyneuropathy). As an example, ulnar motor conduction velocity slowing across the elbow segment may be consistent with a very mild neuropathy. Similarly, evidence for cervical radiculopathy or polyradiculopathy can be identified in asymptomatic older individuals on electrodiagnostic testing or magnetic resonance imaging. However, electrophysiologic and radiologic findings alone generally are not sufficient to diagnose a particular syndrome. Thus, if mild slowing across the wrist in the median nerve is detected without associated symptoms, a diagnosis of mild median neuropathy at the wrist is identified, not the clinical diagnosis of carpal tunnel syndrome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC TESTING",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Electrodiagnostic studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electromyography (EMG) and nerve conduction studies (NCS) remain the most effective means of identifying and classifying a disorder affecting the upper extremity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/46/1769?source=see_link\">",
"     \"Overview of electromyography\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/31/2554?source=see_link\">",
"     \"Overview of nerve conduction studies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Focal entrapments of the median, radial, or ulnar nerves are generally straightforward to determine using",
"    <span class=\"nowrap\">",
"     EMG/NCS.",
"    </span>",
"    The electromyographer looks for evidence of demyelination (conduction velocity slowing and conduction block) across likely affected segments of nerve, such as the median nerve at the wrist in carpal tunnel syndrome. Similar findings may be found across the elbow segment in ulnar neuropathy and across the spiral groove in radial neuropathy. Electromyography tends to be mainly confirmatory and will give some insight into lesion severity.",
"   </p>",
"   <p>",
"    In plexopathies, abnormalities are usually found in several nerves emanating from one region of the plexus, such as the upper trunk. Studying conduction across the plexus is generally not performed for technical reasons; thus, the usual findings of demyelination cannot be sought. Instead, testing is confined to distal segments and a search for axon loss is pursued. As an example, in a patient with an upper trunk lesion, reductions in the amplitude of the median, radial, and musculocutaneous sensory responses are typical. Since both standard median and ulnar motor testing are confined to lower trunk muscles, these studies are usually normal. However, on needle examination, muscles innervated by upper trunk fibers can be studied; in these, fibrillation potentials, positive sharp waves, and chronic reinnervation may be identified. In lower trunk problems, ulnar and medial antebrachial cutaneous sensory responses are reduced while ulnar and median motor studies can both show abnormalities. On electromyography, evidence of denervation and chronic reinnervation may be found in C8 to T1 muscles.",
"   </p>",
"   <p>",
"    In radiculopathy, sensory responses are spared since the lesion is proximal to the dorsal root ganglion. Motor studies are usually also normal, unless the C8 to T1 roots are affected. Abnormalities typically are identified only on needle examination and affect the muscles derived from the involved roots.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Imaging is the best first study to obtain in some patients. As an example, magnetic resonance imaging of the cervical spine is probably the best first test in a patient with radiating neck pain, sensory loss over digits 2 to 4, and weakness in C7 muscles. However, in many situations a patient's complaints are more nondescript. Pain may be nonfocal, weakness minimally present, and no fixed sensory loss identified. In these situations EMG is probably the first test to pursue and, depending upon the results, imaging of the appropriate area can be performed subsequently if needed. In one study, although imaging with MRI was found to be in agreement with EMG findings in 60 percent of cases, it provided different information in 40 percent, suggesting that the two modalities often provide complementary information [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The utility of plain films generally is limited, with a few exceptions.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cervical spine films with extension and flexion may be helpful in sorting out cervical instability and will give a sense of the degree of degeneration. Loss of disc space at one level may suggest a herniated nucleus pulposus. Straightening of the normal cervical lordosis may suggest paraspinal muscle spasm. Osteolytic lesions can be identified.",
"     </li>",
"     <li>",
"      Chest x-ray may be helpful in determining the cause of a lower trunk plexopathy when lesions in the apex of the lung are responsible. The presence or absence of a cervical rib also can be determined. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/53/2906?source=see_link\">",
"       \"Brachial plexus syndromes\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Plain films of the distal arm are rarely indicated, except in cases of trauma or when a palpable mass lesion is present.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    MRI has become the mainstay of most neurologic imaging. In cervical spine disease, specifics of disc herniation, degeneration, and degree of compression of a certain root has made this tool invaluable, especially when considering a surgical option. In patients with idiopathic plexopathies, one-time imaging is probably warranted to exclude the possibility of a mass lesion in the region, especially in those with worsening symptoms or a history of neoplastic disease. MRI of nerves is occasionally performed after",
"    <span class=\"nowrap\">",
"     EMG/NCS",
"    </span>",
"    has suggested a specific location for the problem. In a patient with acute onset carpal tunnel syndrome, for example, MRI of the wrist has revealed tumor in some patients.",
"   </p>",
"   <p>",
"    Ultrasound is being investigated as a supplementary diagnostic technique in disorders such as carpal tunnel syndrome and ulnar neuropathy at the elbow. In the former, enlargement of the median nerve within the carpal tunnel has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/6\">",
"     6",
"    </a>",
"    ]. However, ultrasound has not gained widespread use.",
"   </p>",
"   <p>",
"    CT has some utility for patients who have pacemakers or who cannot use an MRI for other reasons. CT combined with myelography gives useful information regarding nerve roots in patients with cervical disc disease, but again it is rarely performed and then mainly in individuals who cannot undergo MRI. CT also provides helpful information regarding osseous structures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Serologic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serologic testing is usually of limited value in patients presenting with focal symptoms affecting the arm. However, some tests are worth considering:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Thyroid function tests in patients with carpal tunnel syndrome",
"     </li>",
"     <li>",
"      Fasting glucose in patients with carpal tunnel syndrome, especially if a mild polyneuropathy may also be present",
"     </li>",
"     <li>",
"      Lyme titers in patients with polyradiculopathy, especially in endemic areas",
"     </li>",
"     <li>",
"      Hereditary neuropathy with predisposition to pressure palsy gene test in patients with multiple mononeuropathies (affecting at least two extremities)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In patients with mononeuropathy multiplex, many other laboratory studies are warranted in an attempt to identify the underlying disorder. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/53/16215?source=see_link\">",
"     \"Diagnosis and treatment of vasculitic neuropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Lumbar puncture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lumbar puncture is warranted in patients with unusual presentations of radiculopathy. The cerebrospinal fluid (CSF) should be examined for evidence of inflammation (including elevated CSF protein and mononuclear cells) and serologic testing for Lyme disease and syphilis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     MEDIAN NERVE SYNDROMES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Carpal tunnel syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The carpal tunnel is formed by the transverse carpal ligament (flexor retinaculum) superiorly and the carpal bones inferiorly (",
"    <a class=\"graphic graphic_figure graphicRef59856 \" href=\"UTD.htm?1/28/1477\">",
"     figure 2",
"    </a>",
"    ). The median nerve, accompanied by the nine flexor tendons of the forearm musculature, must pass through this anatomic tunnel (",
"    <a class=\"graphic graphic_figure graphicRef53265 \" href=\"UTD.htm?18/45/19158\">",
"     figure 3",
"    </a>",
"    ). The pathophysiology of carpal tunnel syndrome is multifactorial. Increased pressure in the intracarpal canal is thought to play a key role in the development of clinical CTS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/22/23911?source=see_link\">",
"     \"Etiology of carpal tunnel syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Carpal tunnel syndrome is the most common upper extremity mononeuropathy. Symptoms usually include painful paresthesias in a distribution that includes the median nerve territory, with involvement of the first three digits and the radial half of the fourth digit (",
"    <a class=\"graphic graphic_figure graphicRef70720 \" href=\"UTD.htm?37/44/38593\">",
"     figure 4",
"    </a>",
"    ). The symptoms are typically worse at night and characteristically awaken affected patients from sleep. However, there is a wide range of variability. The pain and paresthesia may be localized to the wrist or involve the entire hand. It is not uncommon for sensory symptoms to radiate proximally into the forearm, and less frequently to radiate above the elbow to the shoulder. Fixed sensory loss and weakness may develop as entrapment of the median nerve grows more severe. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42230?source=see_link\">",
"     \"Clinical manifestations and diagnosis of carpal tunnel syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment of carpal tunnel syndrome consists of conservative therapy with wrist splinting, especially at night or while performing activities that exacerbate symptoms. If this fails, steroid injection into the wrist is often helpful in relieving symptoms (at least temporarily in a majority of cases). Surgical release of the flexor retinaculum is indicated in more severe cases; results are usually quite good. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/62/44008?source=see_link\">",
"     \"Treatment of carpal tunnel syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Pronator teres syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Entrapment of the median nerve occasionally occurs in the proximal forearm at the site where the nerve passes through the pronator teres muscle. This syndrome generally occurs in physically active people such as professional bicycle riders and is rare. Patients may present with forearm pain and sensory loss involving the entire lateral palm. Sensory loss over the thenar eminence is also typical, differentiating this disorder from carpal tunnel syndrome, in which sensation in that area is spared.",
"   </p>",
"   <p>",
"    Electrophysiologic testing reveals slowed conduction velocity in the forearm and, in severe cases, conduction block. Needle examination may demonstrate abnormalities in median innervated forearm muscles, including the flexor carpi radialis.",
"   </p>",
"   <p>",
"    Treatment of the pronator teres syndrome usually requires a reduction in the symptom promoting activity. Nonsteroidal antiinflammatory drugs may provide some pain relief; injection into the tender sites of the pronator teres muscle with a corticosteroid and local anesthetic agent (10 to 20 mg of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/25/31129?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    acetate, and 1 mL of 1 percent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    hydrochloride using a #23 or #25 needle) is useful if pain continues. Surgery aimed at decompressing the nerve within the pronator teres muscle is helpful if the disability persists for several months despite these measures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Anterior interosseous neuropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The anterior interosseous nerve branches off from the median nerve in the region of the elbow. It then descends the anterior forearm, innervating several muscles including the flexor pollicis longus, the deep flexors of digits 2 and 3, and pronator quadratus. It does not subserve cutaneous sensation; thus, nerve dysfunction is characterized by weakness of this group of muscles only. On examination, the patient cannot make a standard \"O\" (as in \"okay\") with the thumb and forefinger.",
"   </p>",
"   <p>",
"    Isolated injury to the anterior interosseous nerve is distinctly rare, although may occur with significant trauma to the forearm. More commonly, anterior interosseous neuropathy develops in patients who present with neuralgic amyotrophy (brachial neuritis). (See",
"    <a class=\"local\" href=\"#H41\">",
"     'Brachial plexopathy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Other disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;More proximal median nerve compression rarely can occur in the region just above the elbow in some adults who have a small band attached to the distal humerus (the ligament of Struthers). The median nerve is most prone to infarction in a similar region just proximal to the elbow in patients with a vasculitic process. In both of these disorders, the clinical finding of weakness in multiple median and anterior interosseous innervated muscles is helpful. Electrophysiologically, fibrillation potentials and positive waves may also be identified in these muscles. Sensory loss remains confined to the lateral aspect of the hand.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     ULNAR NERVE SYNDROMES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Ulnar neuropathy at the elbow and wrist",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ulnar neuropathy at the elbow and wrist is reviewed here briefly and discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/12/38089?source=see_link\">",
"     \"Ulnar neuropathy at the elbow and wrist\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Ulnar neuropathy at the elbow (",
"    <a class=\"graphic graphic_figure graphicRef68935 \" href=\"UTD.htm?33/62/34785\">",
"     figure 5",
"    </a>",
"    ) is the second most common compression neuropathy affecting the upper extremities. In mild cases, symptoms include sensory loss and paresthesias over digits 4 and 5 (",
"    <a class=\"graphic graphic_figure graphicRef76075 \" href=\"UTD.htm?23/56/24448\">",
"     figure 6",
"    </a>",
"    ). In more severe cases, weakness of the interosseous muscles of the hand becomes apparent and the patient may complain of worsened grip and clumsiness. Pain in the region of the elbow also is common, although not universal. Involvement of ulnar innervated forearm muscles leads to weakness in finger and wrist flexion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/12/38089?source=see_link&amp;anchor=H19484203#H19484203\">",
"     \"Ulnar neuropathy at the elbow and wrist\", section on 'Clinical features'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/12/38089?source=see_link&amp;anchor=H87963056#H87963056\">",
"     \"Ulnar neuropathy at the elbow and wrist\", section on 'Ulnar neuropathy at the elbow'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Compression of the ulnar nerve occasionally occurs in the wrist (",
"    <a class=\"graphic graphic_figure graphicRef57601 \" href=\"UTD.htm?15/0/15364\">",
"     figure 7",
"    </a>",
"    ). Like the median nerve, the ulnar nerve travels through its own tunnel into the wrist, known as Guyon's canal. Compression of the nerve can occur in the canal itself or distal, in the proximal hand. Compression at the wrist may appear clinically similar to that at the elbow: weakness in the interossei muscles and sensory loss and paresthesias affecting digits 4 and 5. However, the ulnar innervated finger flexors are spared in this syndrome, and in some individuals the hypothenar muscles are less affected than some of the other hand muscles, such as the first dorsal interosseous. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/12/38089?source=see_link&amp;anchor=H87963063#H87963063\">",
"     \"Ulnar neuropathy at the elbow and wrist\", section on 'Ulnar neuropathy at the wrist'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In most cases, the diagnosis of ulnar neuropathy can be confirmed by electrodiagnostic testing or imaging when suspected on the basis of clinical symptoms or signs. There are a number of provocative maneuvers for ulnar neuropathy, but the sensitivity and specificity of these maneuvers appears to be suboptimal. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/12/38089?source=see_link&amp;anchor=H19485578#H19485578\">",
"     \"Ulnar neuropathy at the elbow and wrist\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with mild ulnar neuropathy who typically present with intermittent sensory symptoms and electrodiagnostic features of conduction slowing across the elbow often improve with conservative measures or remain stable over years. Those with persistent sensory loss and weakness without wasting often present acutely (sometimes with a milder pre-existing history of intermittent symptoms) and commonly have features of both conduction block and slowing on electrodiagnostic testing. This group often improves over the course of three to six months, based upon clinical and electrodiagnostic measures. Those with persistent symptoms of weakness and numbness beyond six months should be referred for consideration of surgical intervention. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/12/38089?source=see_link&amp;anchor=H26073200#H26073200\">",
"     \"Ulnar neuropathy at the elbow and wrist\", section on 'Management'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/12/38089?source=see_link&amp;anchor=H626065#H626065\">",
"     \"Ulnar neuropathy at the elbow and wrist\", section on 'Conservative treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The management of ulnar neuropathy at the wrist is directed by the results of the clinical scenario and imaging. Patients with traumatic causes or with evidence of extrinsic or intrinsic neural compression should be referred for consideration of surgical treatment.",
"   </p>",
"   <p>",
"    Patients with severe weakness, wasting, and persistent sensory loss due to ulnar neuropathy at the elbow or wrist will show evidence of axonal injury on electrodiagnostic testing. In younger patients, or when the presentation is acute (less than six months) consideration should be given to surgical referral. However, for very elderly or medically unwell patients, and for patients with chronic (two years or longer) severe involvement, the benefit of surgical intervention is doubtful. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/12/38089?source=see_link&amp;anchor=H26073215#H26073215\">",
"     \"Ulnar neuropathy at the elbow and wrist\", section on 'Surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Miscellaneous syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ulnar neuropathy rarely may occur as the nerve exits the cubital tunnel. In diabetic patients, ulnar neuropathy can occur in the forearm. In vasculitic processes, infarction of the nerve generally occurs just proximal to the elbow.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h1\">",
"     RADIAL NERVE SYNDROMES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h2\">",
"     Radial neuropathy at the spiral groove",
"    </span>",
"    &nbsp;&mdash;&nbsp;The radial nerve descends down the medial upper arm before wrapping around the mid-humerus and taking a more posterior course. The nerve is particularly predisposed to compression in the region where it runs adjacent to the humerus, known as the spiral groove. Compression of the nerve in this area often occurs after prolonged pressure on the nerve. The term \"Saturday night palsy\" has been applied to this disorder since inebriated individuals frequently develop the problem.",
"   </p>",
"   <p>",
"    On examination, the triceps retains full strength but there is weakness of the wrist extensors (ie, \"wrist drop\"), finger extensors, and brachioradialis. Sensory loss over the dorsum of the hand, possibly extending up the posterior forearm, may also be present. The best way to determine subtle brachioradialis weakness is to have the patient keep the forearm midway between pronation and supination (in a \"banging the table\" position), asking the patient to flex the forearm against resistance and then assessing the bulk of the muscle by palpation, comparing it with the unaffected side.",
"   </p>",
"   <p>",
"    Associated weakness in ulnar-innervated hand muscles and in thumb abduction is also often present, the former likely related to difficulties in performing the action in the absence of the stabilizing influence of the finger extensors. Thumb abduction is affected as abductor pollicis longus is a radial-innervated muscle.",
"   </p>",
"   <p>",
"    Acute radial neuropathies at the spiral groove are sometimes difficult to distinguish from a central nervous system lesion producing arm weakness. Most central disorders that cause arm weakness tend to affect the extensors greater than the flexors. Thus, weakness in extension of the wrist (ie, wrist drop) and fingers may be an ambiguous finding. Relative preservation of triceps strength and sensory loss isolated to the dorsum of the hand are helpful findings indicative of radial neuropathy at the spiral groove. Most importantly, the brachioradialis should also be weak in a radial nerve lesion, but is typically less affected in a central disorder.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h2\">",
"     Posterior interosseous neuropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The posterior interosseous nerve branches off from the radial nerve just proximal to the elbow and innervates the extensor muscles of the forearm. The radial nerve descends down the forearm as the superficial radial nerve with no motor component, providing cutaneous sensation to the dorsum of the hand.",
"   </p>",
"   <p>",
"    In most cases pain is the only significant problem associated with a posterior interosseous neuropathy. Provocative pain with extension of the middle finger and relief of pain with nerve block may help identify mild problems [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/7\">",
"     7",
"    </a>",
"    ]. Persistent pain in cases of severe lateral epicondylitis (tennis elbow) has been attributed to compression of the nerve in this region. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1354?source=see_link\">",
"     \"Epicondylitis (tennis and golf elbow)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Like anterior interosseous neuropathy, posterior interosseous neuropathy can also occur as part of brachial neuritis. (See",
"    <a class=\"local\" href=\"#H41\">",
"     'Brachial plexopathy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A posterior interosseous neuropathy also should be considered in patients with weakness of the finger extensors that spares the more proximal muscles including brachioradialis and extensor carpi radialis. In severe cases, detailed examination may reveal medial deviation of the wrist with wrist extension secondary to involvement of extensor carpi ulnaris and sparing of extensor carpi radialis. Forearm supination is also weak.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conservative treatment is generally the rule for patients with a one-time compression injury to the radial nerve (such as a radial Saturday night palsy). Physical therapy, wrist splinting (to maintain function), and pain management are most important. Prognosis for full recovery is generally good. In a retrospective study of 51 patients with compressive radial neuropathy, follow-up was available for 23, and all experienced complete clinical recovery over a mean of 3.4 months (range 0.5 to 6 months) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In patients with severe injury secondary to trauma, follow-up examinations and electromyography may be warranted. Severe ongoing nerve compression or transection may be difficult to distinguish from a single episode of injury that occurred at the time of trauma. Lack of any improvement, either clinically or electrophysiologically, warrants further imaging or surgical exploration.",
"   </p>",
"   <p>",
"    In patients with posterior interosseous neuropathy in the forearm, surgical intervention aimed at decompressing the nerve can be helpful if the diagnosis is reasonably secure [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/7\">",
"     7",
"    </a>",
"    ]. However, the possibility that it is a manifestation of neuralgic amyotrophy should be considered. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/53/2906?source=see_link&amp;anchor=H13#H13\">",
"     \"Brachial plexus syndromes\", section on 'Neuralgic amyotrophy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h1\">",
"     PROXIMAL NEUROPATHIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of other isolated focal neuropathies may affect the upper extremity, including suprascapular neuropathy, long thoracic neuropathy, and axillary neuropathy. These disorders are uncommon. Suprascapular neuropathy and axillary neuropathies may present with weakness in arm abduction and external rotation; long thoracic neuropathy usually produces winging of the scapula (",
"    <a class=\"graphic graphic_picture graphicRef68399 \" href=\"UTD.htm?1/47/1791\">",
"     picture 1",
"    </a>",
"    ). Sensory loss and paresthesias occur only with axillary neuropathies. Pain is usually present in all of these disorders. Electromyography and nerve conduction studies identify abnormalities confined to muscles of the affected nerve.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H572707751\">",
"    <span class=\"h2\">",
"     Suprascapular neuropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The suprascapular nerve originates from the upper trunk of the brachial plexus (",
"    <a class=\"graphic graphic_figure graphicRef50576 \" href=\"UTD.htm?34/25/35222\">",
"     figure 1",
"    </a>",
"    ). It carries sensory fibers from the glenohumeral and acromioclavicular joints, and provides motor supply to the supraspinatus and infraspinatus muscles. Injury most often occurs due to entrapment at the suprascapular notch and less often at the spinoglenoid notch [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/9\">",
"     9",
"    </a>",
"    ]. Shoulder pain is prominent in most patients with impingement at the suprascapular notch, along with weakness of the supraspinatus (shoulder abduction) and infraspinatus (external shoulder rotation) muscles. Atrophy may be evident as well. In contrast, suprascapular nerve injury at the level of the spinoglenoid notch results in painless weakness of external shoulder rotation and atrophy of the infraspinatus.",
"   </p>",
"   <p>",
"    Direct trauma is a common cause of suprascapular neuropathy, such as can occur from a football tackle, a fall, or a rotator cuff tear [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. The nerve can also be injured by activities involving stretch, traction or repetitive movement, as has been reported in weight lifters, volleyball players, baseball players, and gymnasts [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/11-13\">",
"     11-13",
"    </a>",
"    ]. Rarely, the suprascapular nerve is injured by compression from masses such as a ganglion cyst or tumor. In one study of 27 patients with entrapment of the suprascapular nerve who had perineural masses identified by MRI, 21 were ganglion cysts and 5 were malignant tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis of suprascapular nerve entrapment may be suspected on the basis of clinical findings including pain, muscle weakness and atrophy, and limited scapulothoracic movement. While electrodiagnostic testing and imaging studies may help confirm a clinical disorder, many cases of suspected suprascapular nerve entrapment have negative studies. Thus, continued clinical observation is needed.",
"   </p>",
"   <p>",
"    Treatment and prognosis varies according to the type of nerve injury [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/9\">",
"     9",
"    </a>",
"    ]. For patients with repetitive trauma, avoidance of the precipitating movement is often sufficient to allow recovery, combined with physical therapy and exercise for preserving range of motion and strengthening the shoulder and rotator cuff muscles. Surgical release of the transverse scapular ligament and arthroscopic suprascapular nerve decompression are options for patients who do not improve with conservative management [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. Surgical excision is indicated for those with a cyst or tumor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H572707370\">",
"    <span class=\"h2\">",
"     Long thoracic neuropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The long thoracic nerve is a pure motor nerve that arises from the fifth, sixth, and seventh cervical nerve roots (",
"    <a class=\"graphic graphic_figure graphicRef50576 \" href=\"UTD.htm?34/25/35222\">",
"     figure 1",
"    </a>",
"    ). Dysfunction of the long thoracic nerve leads to paralysis of the serratus anterior muscle, which results in winging of the scapula. To demonstrate winging, the patient presses the outstretched arms against a wall; the involved scapula projects from the thorax as viewed from behind (",
"    <a class=\"graphic graphic_picture graphicRef68399 \" href=\"UTD.htm?1/47/1791\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The main causes of injury to the long thoracic nerve are the following [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/9\">",
"     9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Neuralgic amyotrophy",
"     </li>",
"     <li>",
"      Trauma or compression",
"     </li>",
"     <li>",
"      Stretch or traction from repetitive activities",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In its classic form, neuralgic amyotrophy is characterized by the onset of severe pain followed by patchy weakness in the distribution of a trunk or cord of the brachial plexus or in of the distribution of multiple nerves, usually accompanied by winging of the scapula. In some cases of neuralgic amyotrophy, the long thoracic nerve is involved in isolation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/53/2906?source=see_link&amp;anchor=H13#H13\">",
"     \"Brachial plexus syndromes\", section on 'Neuralgic amyotrophy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Trauma to the long thoracic nerve can occur from a direct blow to the shoulder or lateral chest wall (eg, playing football), from invasive procedures (eg, first rib resection, mastectomy with axillary node dissection, scalenectomies, chest tube insertion, infraclavicular plexus anesthesia, and cardiothoracic surgery) [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/9,18,19\">",
"     9,18,19",
"    </a>",
"    ]. Some cases that present postoperatively are likely caused by neurovascular compression or traction from upper arm positioning during anesthesia. Nerve compression is the presumed mechanism of injury associated with carrying heavy objects such as backpacks across the shoulder. Stretch or traction to the nerve may occur from repetitive motion related to sports or labor, particularly when the arm is in an overhead, outstretched position, and rarely from chiropractic manipulation [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Management and prognosis varies according to the mechanism of nerve injury [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/9\">",
"     9",
"    </a>",
"    ]. Recovery from neuralgic amyotrophy occurs slowly over one to three years (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/53/2906?source=see_link&amp;anchor=H13#H13\">",
"     \"Brachial plexus syndromes\", section on 'Neuralgic amyotrophy'",
"    </a>",
"    ). Most cases of long thoracic nerve injury caused by carrying or by repetitive activity are incomplete and resolve spontaneously within 6 to 24 months. The patient should avoid the precipitating movement and avoid carrying heavy objects across the shoulder [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/9\">",
"     9",
"    </a>",
"    ]. Physical therapy and exercise is important to maintain range of motion and strengthen trapezius and rhomboid muscles. Thoracic nerve injury due to trauma is generally severe and recovery is often limited or does not occur.",
"   </p>",
"   <p>",
"    For those who do not experience functional recovery, surgical procedures may be an option [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/9,21,22\">",
"     9,21,22",
"    </a>",
"    ]. These include various combinations of muscle transfers and fascial grafts (eg, transfer of the sternal head of the pectoralis major muscle). There are also a few case reports of successful treatment with nerve transfer using the thoracodorsal nerve or medial pectoral nerve [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. However, functional limitation due to isolated serratus anterior weakness most often is relatively mild and does not require surgical intervention.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H572708560\">",
"    <span class=\"h2\">",
"     Axillary neuropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The axillary nerve is derived from the posterior cord of the brachial plexus (",
"    <a class=\"graphic graphic_figure graphicRef50576 \" href=\"UTD.htm?34/25/35222\">",
"     figure 1",
"    </a>",
"    ). It carries cutaneous sensory fibers to an oval shaped area over the lateral shoulder and innervates the deltoid (shoulder abduction) and teres minor (shoulder external rotation) muscles. The most common cause of axillary neuropathy is trauma, usually with shoulder dislocation or humeral fracture [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/9\">",
"     9",
"    </a>",
"    ]. Axillary neuropathy can also occur following general anesthesia or sleep in a prone position with the arms raised above the head. In addition, entrapment occurs rarely in the quadrilateral space, which is formed by the teres minor muscle superiorly, the humerus laterally, the long head of the triceps medially, and the teres major muscle inferiorly. The axillary nerve may also be involved as part of the neuralgic amyotrophy syndrome, though seldom in isolation.",
"   </p>",
"   <p>",
"    The clinical features of axillary neuropathy include a sharply-defined region of sensory loss over the lateral shoulder [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/9\">",
"     9",
"    </a>",
"    ]. Weakness is variable and seldom severe, since other muscles assist with shoulder abduction and external rotation.",
"   </p>",
"   <p>",
"    Conservative management includes physical therapy and exercise to preserve range of motion. Recovery is usually underway by three to four months for patients with incomplete nerve injury. Surgical intervention, including nerve grafting, is an option for patients with severe lesions and those who do not improve in the first few months with conservative measures [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/25,26\">",
"     25,26",
"    </a>",
"    ], and for those with recurrent shoulder dislocation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7507778\">",
"    <span class=\"h2\">",
"     Spinal accessory neuropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The spinal accessory nerve is a cranial nerve that is derived from the upper cervical nerve roots and innervates the sternocleidomastoid and trapezius muscles, the latter of which primarily functions as a shoulder stabilizer.",
"   </p>",
"   <p>",
"    The most common causes of isolated spinal accessory neuropathy include biopsy of the cervical lymph nodes in the posterior triangle and local surgery, such as radical neck dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/27\">",
"     27",
"    </a>",
"    ]. Blunt injuries to the nerve are also common (eg, due to sports or combat). In one report, a spinal accessory neuropathy was attributed to a vigorous massage [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinical features of an accessory neuropathy including drooping or depression of the affected shoulder and weakness in abduction [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/27,29\">",
"     27,29",
"    </a>",
"    ]. Atrophy and weakness of sternocleidomastoid is present in more proximal spinal accessory nerve lesions, while more distal lesions lead to atrophy and weakness of the trapezius muscle. Sensory loss is not a feature since the spinal accessory nerve is a pure motor nerve. However, pain is commonly present, perhaps caused by traction on the brachial plexus [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/27\">",
"     27",
"    </a>",
"    ]. Prominent winging of scapula is usually observed.",
"   </p>",
"   <p>",
"    Weakness of the shoulder is most easily demonstrated by having the patient abduct the arm through 180 degrees; in a patient with accessory neuropathy, the last 90 degrees of this maneuver cannot be accomplished. Importantly, the strength of other shoulder muscles such as the deltoid, rhomboids, and serratus anterior cannot be assessed accurately due to the loss of shoulder stabilization.",
"   </p>",
"   <p>",
"    The prognosis will vary by cause. In more severe lesions, muscle transfers can help stabilize the scapula and improve function.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7507770\">",
"    <span class=\"h2\">",
"     Musculocutaneous neuropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The musculocutaneous nerve arises from the lateral cord of the brachial plexus and contains fibers from the C5, C6, and C7 nerve roots. After piercing the coracobrachialis muscle, it courses down the front of the arm between the biceps and brachialis and continues into the forearm as the lateral antebrachial cutaneous nerve. It innervates the coracobrachialis, biceps, and brachialis muscles and supplies cutaneous sensation to the lateral forearm. Clinical features thus include weakness of elbow flexion with associated sensory loss over the lateral forearm.",
"   </p>",
"   <p>",
"    <br/>",
"    Isolated lesions of the musculocutaneous nerve are rare, but the nerve can be injured with direct trauma, shoulder dislocation, strenuous exercise, or malpositioning of the arm during anesthesia [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/30-33\">",
"     30-33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Conservative therapy is usually appropriate [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/33\">",
"     33",
"    </a>",
"    ]. Surgical decompression may be helpful for patients who do not improve with conservative measures [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/33,34\">",
"     33,34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41\">",
"    <span class=\"h1\">",
"     BRACHIAL PLEXOPATHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The brachial plexus (",
"    <a class=\"graphic graphic_figure graphicRef50576 \" href=\"UTD.htm?34/25/35222\">",
"     figure 1",
"    </a>",
"    ) is the most complex structure of the peripheral nervous system [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/35\">",
"     35",
"    </a>",
"    ]. It is vulnerable to trauma and may be affected secondarily by disorders involving adjacent structures. Most brachial plexus disorders show a regional involvement rather than involving the entire brachial plexus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/53/2906?source=see_link\">",
"     \"Brachial plexus syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Localizing a problem to a specific region of the brachial plexus is usually the most important first step in patients with brachial plexopathy. Once that is achieved, it is typically relatively straightforward to identify a specific etiology.",
"   </p>",
"   <p>",
"    A few simple rules can lead to accurate localization of problems to the brachial plexus.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Weakness generally should involve a \"myotomal\" pattern: weakness in C8 to T1 muscles suggests the possibility of a lower",
"      <span class=\"nowrap\">",
"       trunk/medial",
"      </span>",
"      cord problem; weakness in C5 and C6 muscles raises the possibility of an upper",
"      <span class=\"nowrap\">",
"       trunk/lateral",
"      </span>",
"      cord problem; weakness isolated to a single nerve is unlikely to be of plexus origin, except in cases of brachial neuritis",
"     </li>",
"     <li>",
"      Involvement of muscles innervated by the radial or axillary nerves (eg, deltoid, triceps, brachioradialis, wrist extensors, wrist flexors) is consistent with involvement of the posterior cord.",
"     </li>",
"     <li>",
"      Isolated middle trunk plexopathies are almost unheard of; usually some involvement of the lower or upper trunk is also present. A C7 radiculopathy is far more likely.",
"     </li>",
"     <li>",
"      Fixed sensory loss extending into the medial forearm is consistent with a lower",
"      <span class=\"nowrap\">",
"       trunk/medial",
"      </span>",
"      cord plexopathy; sensory loss extending into the lateral forearm is consistent with an upper",
"      <span class=\"nowrap\">",
"       trunk/lateral",
"      </span>",
"      cord plexopathy. The skin in these regions is innervated by nerves that branch off directly from the plexus.",
"     </li>",
"     <li>",
"      Weakness of serratus anterior (causing winging of the scapula), the spinati (causing weakness of arm external rotation and initial abduction), or the rhomboids (retraction and elevation of scapula) makes a radiculopathy or component of radiculopathy more likely since all of these muscles are innervated by nerves that branch off at the very proximal plexus or from the spinal nerves themselves. Brachial neuritis is an important exception to this rule since the serratus anterior is often involved.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Specific disorders of the brachial plexus are reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/53/2906?source=see_link\">",
"     \"Brachial plexus syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42\">",
"    <span class=\"h1\">",
"     CERVICAL RADICULOPATHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A radiculopathy is a pathologic process affecting the nerve root. Cervical radiculopathy is a common cause of both acute and chronic neck pain. This condition is reviewed briefly here, and discussed in greater detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/19/36152?source=see_link\">",
"     \"Clinical features and diagnosis of cervical radiculopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most radiculopathies arise from nerve root compression. The two predominant mechanisms of compressive cervical radiculopathy are cervical spondylosis and disc herniation. Lower cervical roots, particularly C7, are more frequently affected by compression than higher cervical roots.",
"   </p>",
"   <p>",
"    Some causes of noncompressive radiculopathy include infection (especially herpes zoster and Lyme disease), nerve root infarction, infiltration by tumor, infiltration by granulomatous tissue, root avulsion, and demyelination.",
"   </p>",
"   <p>",
"    Pain in the neck, shoulder, or arm occurs in nearly all patients with cervical radiculopathy, but it is usually not helpful for localizing the precise level of the affected root. The pain may be atypical and present as chest pain (pseudo-angina), breast pain, or pain in the face. Head turning, coughing, or sneezing may exacerbate symptoms.",
"   </p>",
"   <p>",
"    In patients with suspected cervical radiculopathy, a major goal of the neurologic evaluation is to look for weakness and sensory disturbance in myotomal and dermatomal patterns. Typical clinical findings of solitary root lesions are summarized in the table (",
"    <a class=\"graphic graphic_table graphicRef74632 \" href=\"UTD.htm?0/56/908\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Neuroimaging and electrodiagnostic testing is indicated when localizing signs and symptoms suggest a nerve root injury or when there are there are persistent symptoms that do not resolve with conservative therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H43\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of patients with cervical radiculopathy is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/47/17144?source=see_link\">",
"     \"Treatment of cervical radiculopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H44\">",
"    <span class=\"h1\">",
"     MISCELLANEOUS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H45\">",
"    <span class=\"h2\">",
"     Focal amyotrophy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Focal or monomelic amyotrophy (including one form known as Hirayama disease) is an unusual disorder, characterized by pure motor weakness of one extremity, which represents a restricted form of motor neuron disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/34/16938?source=see_link&amp;anchor=H26#H26\">",
"     \"Diagnosis of amyotrophic lateral sclerosis and other forms of motor neuron disease\", section on 'Monomelic amyotrophy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H46\">",
"    <span class=\"h2\">",
"     Mononeuropathy multiplex",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ischemic lesions affecting multiple nerves may produce a confusing clinical picture. However, in most patients more widespread nerve involvement, including in the legs, is present.",
"   </p>",
"   <p>",
"    Treatment of the underlying disease remains the rule for management of mononeuropathy multiplex. Recovery can be remarkably good in patients with forms responsive to immunosuppression despite initial severe nerve damage. Patients with varied causes of vasculitis (including Churg-Strauss disease, rheumatoid arthritis, Wegener's granulomatosis, among others), may have significant improvement in neurologic disability in response to immunosuppression. Mononeuropathy multiplex due to vasculitis, either systemic or localized to the nerves only, is discussed in more detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/57/22423?source=see_link\">",
"     \"Clinical manifestations of vasculitic neuropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H47\">",
"    <span class=\"h2\">",
"     Multifocal motor neuropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multifocal motor neuropathy (MMN), also known as multifocal motor neuropathy with conduction block, is a rare demyelinating neuropathy characterized by lower motor neuron signs that often present in a bibrachial pattern, producing arm and hand weakness without associated sensory loss [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. However, MMN can also present the legs. In one series of 88 patients, onset of muscle weakness involving the distal arm or distal leg was noted in 61 and 34 percent of patients, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Usually the neuronal involvement in MMN is patchy, with some nerves unaffected and others severely involved. Motor nerve conduction studies often show evidence of conduction block, representing focal demyelination. Sensory conduction through the same segment of nerve is normal. Elevated titers of GM1 antibodies may be seen in 30 to 80 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/36,39,40\">",
"     36,39,40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Multifocal motor neuropathy is treatable with intravenous immune globulin and other forms of immunosuppression [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/37,38,41-44\">",
"     37,38,41-44",
"    </a>",
"    ]. As an example, one double-blind, placebo-controlled trial found that seven of nine patients who received IVIG first responded after four months of treatment, compared with two of nine patients treated with placebo first [",
"    <a class=\"abstract\" href=\"UTD.htm?8/44/8906/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H48\">",
"    <span class=\"h2\">",
"     Zoster radiculoganglionitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with herpes zoster may develop, in addition to a painful rash, weakness and sensory loss in a nerve distribution close to that of the rash. Inflammation involves the nerve roots and dorsal root ganglion, potentially producing prominent neurogenic injury. Occasionally an associated myelopathy is also present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H491173405\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The major mechanisms of upper extremity peripheral nerve injury are compression, transection, ischemia, inflammation, neuronal degeneration, and radiation exposure. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Carpal tunnel syndrome is the most frequent mononeuropathy affecting the upper extremities, while ulnar neuropathy at the elbow is the second most frequent. Cervical radiculopathy is also common. (See",
"      <a class=\"local\" href=\"#H491173463\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Electromyography and nerve conduction studies are useful for identifying and classifying peripheral nerve disorders affecting the upper extremity. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Diagnostic testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The hallmark of classic carpal tunnel syndrome is pain or paresthesia in a distribution that includes the median nerve territory, with involvement of the lateral portion of the hand (",
"      <a class=\"graphic graphic_figure graphicRef70720 \" href=\"UTD.htm?37/44/38593\">",
"       figure 4",
"      </a>",
"      ). The symptoms are typically worse at night and characteristically awaken affected individuals from sleep. Conservative therapy involves wrist splinting, while glucocorticoid injection and surgical release are options for moderate to severe carpal tunnel syndrome that is refractory to more conservative measures. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Carpal tunnel syndrome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Rare median nerve syndromes include entrapment where the median nerve passes through the pronator teres muscle and isolated injury to the anterior interosseous nerve that branches off from the median nerve in the region of the elbow. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Pronator teres syndrome'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H29\">",
"       'Anterior interosseous neuropathy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ulnar neuropathy at the elbow (",
"      <a class=\"graphic graphic_figure graphicRef68935 \" href=\"UTD.htm?33/62/34785\">",
"       figure 5",
"      </a>",
"      ) is the second most common compression neuropathy affecting the upper extremities. In mild cases, symptoms include sensory loss and paresthesias over digits 4 and 5 (",
"      <a class=\"graphic graphic_figure graphicRef76075 \" href=\"UTD.htm?23/56/24448\">",
"       figure 6",
"      </a>",
"      ). In more severe cases, there is weakness of the interosseous muscles of the hand. Compression of the ulnar nerve occasionally occurs in the wrist (",
"      <a class=\"graphic graphic_figure graphicRef57601 \" href=\"UTD.htm?15/0/15364\">",
"       figure 7",
"      </a>",
"      ) and may appear clinically similar to that at the elbow. However, the ulnar innervated finger flexors are spared in this syndrome. Mild ulnar neuropathy at the elbow often improves with conservative measures or remains stable. Those with persistent symptoms of weakness and numbness beyond six months should be referred for consideration of surgical intervention. (See",
"      <a class=\"local\" href=\"#H31\">",
"       'Ulnar nerve syndromes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The radial nerve is predisposed to compression in the region where it runs adjacent to the humerus, known as the spiral groove. The triceps retains full strength but there is weakness of the wrist extensors (ie, wrist drop), finger extensors, and brachioradialis. Sensory loss over the dorsum of the hand, possibly extending up the posterior forearm, may also be present. With posterior interosseous neuropathy, forearm pain and weakness of finger dorsiflexion is typical. Conservative treatment is generally the rule for patients with a one-time compression injury to the radial nerve. In patients with posterior interosseous neuropathy in the forearm, surgical intervention aimed at decompressing the nerve can be helpful if the diagnosis is reasonably secure, unless it is thought to be due to neuralgic amyotrophy. (See",
"      <a class=\"local\" href=\"#H36\">",
"       'Radial nerve syndromes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Proximal focal neuropathies of the upper extremity include suprascapular neuropathy, long thoracic neuropathy, and axillary neuropathy. (See",
"      <a class=\"local\" href=\"#H40\">",
"       'Proximal neuropathies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The brachial plexus (",
"      <a class=\"graphic graphic_figure graphicRef50576 \" href=\"UTD.htm?34/25/35222\">",
"       figure 1",
"      </a>",
"      ) is vulnerable to trauma and may be affected secondarily by disorders involving adjacent structures. Most brachial plexus disorders show a regional involvement rather than involving the entire brachial plexus. (See",
"      <a class=\"local\" href=\"#H41\">",
"       'Brachial plexopathy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cervical radiculopathy is a common cause of both acute and chronic neck pain. Most radiculopathies arise from nerve root compression due to cervical spondylosis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      disc herniation. Lower cervical roots, particularly C7, are more frequently affected by compression. Some causes of noncompressive radiculopathy include infection (especially herpes zoster and Lyme disease), nerve root infarction, infiltration by tumor, infiltration by granulomatous tissue, root avulsion, and demyelination. Typical clinical findings of solitary root lesions are summarized in the table (",
"      <a class=\"graphic graphic_table graphicRef74632 \" href=\"UTD.htm?0/56/908\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H42\">",
"       'Cervical radiculopathy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Additional uncommon peripheral nerve syndromes affecting the upper extremities include focal amyotrophy, mononeuropathy multiplex, multifocal motor neuropathy, and zoster radiculoganglionitis. (See",
"      <a class=\"local\" href=\"#H44\">",
"       'Miscellaneous'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/1\">",
"      de Krom MC, Knipschild PG, Kester AD, et al. Carpal tunnel syndrome: prevalence in the general population. J Clin Epidemiol 1992; 45:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/2\">",
"      Stevens JC, Sun S, Beard CM, et al. Carpal tunnel syndrome in Rochester, Minnesota, 1961 to 1980. Neurology 1988; 38:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/3\">",
"      Radhakrishnan K, Litchy WJ, O'Fallon WM, Kurland LT. Epidemiology of cervical radiculopathy. A population-based study from Rochester, Minnesota, 1976 through 1990. Brain 1994; 117 ( Pt 2):325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/4\">",
"      Beghi E, Kurland LT, Mulder DW, Nicolosi A. Brachial plexus neuropathy in the population of Rochester, Minnesota, 1970-1981. Ann Neurol 1985; 18:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/5\">",
"      Nardin RA, Patel MR, Gudas TF, et al. Electromyography and magnetic resonance imaging in the evaluation of radiculopathy. Muscle Nerve 1999; 22:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/6\">",
"      Nakamichi KI, Tachibana S. Enlarged median nerve in idiopathic carpal tunnel syndrome. Muscle Nerve 2000; 23:1713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/7\">",
"      Barnum M, Mastey RD, Weiss AP, Akelman E. Radial tunnel syndrome. Hand Clin 1996; 12:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/8\">",
"      Arnold WD, Krishna VR, Freimer M, et al. Prognosis of acute compressive radial neuropathy. Muscle Nerve 2012; 45:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/9\">",
"      Goslin KL, Krivickas LS. Proximal neuropathies of the upper extremity. Neurol Clin 1999; 17:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/10\">",
"      Boykin RE, Friedman DJ, Higgins LD, Warner JJ. Suprascapular neuropathy. J Bone Joint Surg Am 2010; 92:2348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/11\">",
"      Cummins CA, Schneider DS. Peripheral nerve injuries in baseball players. Neurol Clin 2008; 26:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/12\">",
"      Dramis A, Pimpalnerkar A. Suprascapular neuropathy in volleyball players. Acta Orthop Belg 2005; 71:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/13\">",
"      Romeo AA, Rotenberg DD, Bach BR Jr. Suprascapular neuropathy. J Am Acad Orthop Surg 1999; 7:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/14\">",
"      Fritz RC, Helms CA, Steinbach LS, Genant HK. Suprascapular nerve entrapment: evaluation with MR imaging. Radiology 1992; 182:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/15\">",
"      Shah AA, Butler RB, Sung SY, et al. Clinical outcomes of suprascapular nerve decompression. J Shoulder Elbow Surg 2011; 20:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/16\">",
"      Lafosse L, Tomasi A, Corbett S, et al. Arthroscopic release of suprascapular nerve entrapment at the suprascapular notch: technique and preliminary results. Arthroscopy 2007; 23:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/17\">",
"      Piasecki DP, Romeo AA, Bach BR Jr, Nicholson GP. Suprascapular neuropathy. J Am Acad Orthop Surg 2009; 17:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/18\">",
"      Kauppila LI, Vastam&auml;ki M. Iatrogenic serratus anterior paralysis. Long-term outcome in 26 patients. Chest 1996; 109:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/19\">",
"      Krasna MJ, Forti G. Nerve injury: injury to the recurrent laryngeal, phrenic, vagus, long thoracic, and sympathetic nerves during thoracic surgery. Thorac Surg Clin 2006; 16:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/20\">",
"      Oware A, Herskovitz S, Berger AR. Long thoracic nerve palsy following cervical chiropractic manipulation. Muscle Nerve 1995; 18:1351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/21\">",
"      Galano GJ, Bigliani LU, Ahmad CS, Levine WN. Surgical treatment of winged scapula. Clin Orthop Relat Res 2008; 466:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/22\">",
"      Connor PM, Yamaguchi K, Manifold SG, et al. Split pectoralis major transfer for serratus anterior palsy. Clin Orthop Relat Res 1997; :134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/23\">",
"      Novak CB, Mackinnon SE. Surgical treatment of a long thoracic nerve palsy. Ann Thorac Surg 2002; 73:1643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/24\">",
"      Tomaino MM. Neurophysiologic and clinical outcome following medial pectoral to long thoracic nerve transfer for scapular winging: a case report. Microsurgery 2002; 22:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/25\">",
"      Steinmann SP, Moran EA. Axillary nerve injury: diagnosis and treatment. J Am Acad Orthop Surg 2001; 9:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/26\">",
"      Perlmutter GS. Axillary nerve injury. Clin Orthop Relat Res 1999; :28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/27\">",
"      Wills AJ, Sawle GV. Accessory nerve palsies. Pract Neurol 2010; 10:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/28\">",
"      Aksoy IA, Schrader SL, Ali MS, et al. Spinal accessory neuropathy associated with deep tissue massage: a case report. Arch Phys Med Rehabil 2009; 90:1969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/29\">",
"      Kelley MJ, Kane TE, Leggin BG. Spinal accessory nerve palsy: associated signs and symptoms. J Orthop Sports Phys Ther 2008; 38:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/30\">",
"      Dundore DE, DeLisa JA. Musculocutaneous nerve palsy: an isolated complication of surgery. Arch Phys Med Rehabil 1979; 60:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/31\">",
"      Kim SM, Goodrich JA. Isolated proximal musculocutaneous nerve palsy: case report. Arch Phys Med Rehabil 1984; 65:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/32\">",
"      Hsu JC, Paletta GA Jr, Gambardella RA, Jobe FW. Musculocutaneous nerve injury in major league baseball pitchers: a report of 2 cases. Am J Sports Med 2007; 35:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/33\">",
"      Besleaga D, Castellano V, Lutz C, Feinberg JH. Musculocutaneous neuropathy: case report and discussion. HSS J 2010; 6:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/34\">",
"      Yilmaz C, Eskandari MM, Colak M. Traumatic musculocutaneous neuropathy: a case report. Arch Orthop Trauma Surg 2005; 125:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/35\">",
"      Ferrante MA. Brachial plexopathies: classification, causes, and consequences. Muscle Nerve 2004; 30:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/36\">",
"      Pestronk A, Cornblath DR, Ilyas AA, et al. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 1988; 24:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/37\">",
"      Slee M, Selvan A, Donaghy M. Multifocal motor neuropathy: the diagnostic spectrum and response to treatment. Neurology 2007; 69:1680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/38\">",
"      Cats EA, van der Pol WL, Piepers S, et al. Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy. Neurology 2010; 75:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/39\">",
"      Kornberg AJ, Pestronk A. The clinical and diagnostic role of anti-GM1 antibody testing. Muscle Nerve 1994; 17:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/40\">",
"      Pestronk A. Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies. Muscle Nerve 1991; 14:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/41\">",
"      L&eacute;ger JM, Chassande B, Musset L, et al. Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study. Brain 2001; 124:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/42\">",
"      Van den Berg LH, Kerkhoff H, Oey PL, et al. Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 1995; 59:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/43\">",
"      Federico P, Zochodne DW, Hahn AF, et al. Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study. Neurology 2000; 55:1256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?8/44/8906/abstract/44\">",
"      Patwa HS, Chaudhry V, Katzberg H, et al. Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2012; 78:1009.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5282 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-115.25.216.6-2972EEEA2C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_44_8906=[""].join("\n");
var outline_f8_44_8906=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H491173405\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Compression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Transection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Nerve ischemia/infarct",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Radiation-induced injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Inflammation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Degeneration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Metabolic",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H491173463\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DIAGNOSTIC TESTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Electrodiagnostic studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Serologic testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Lumbar puncture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      MEDIAN NERVE SYNDROMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Carpal tunnel syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Pronator teres syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Anterior interosseous neuropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Other disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      ULNAR NERVE SYNDROMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Ulnar neuropathy at the elbow and wrist",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Miscellaneous syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      RADIAL NERVE SYNDROMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      Radial neuropathy at the spiral groove",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      Posterior interosseous neuropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      PROXIMAL NEUROPATHIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H572707751\">",
"      Suprascapular neuropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H572707370\">",
"      Long thoracic neuropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H572708560\">",
"      Axillary neuropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7507778\">",
"      Spinal accessory neuropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7507770\">",
"      Musculocutaneous neuropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H41\">",
"      BRACHIAL PLEXOPATHY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H42\">",
"      CERVICAL RADICULOPATHY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H43\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H44\">",
"      MISCELLANEOUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H45\">",
"      Focal amyotrophy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H46\">",
"      Mononeuropathy multiplex",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H47\">",
"      Multifocal motor neuropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H48\">",
"      Zoster radiculoganglionitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H491173405\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/5282\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5282|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/25/35222\" title=\"figure 1\">",
"      Trunks and cords of the brachial plexus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/28/1477\" title=\"figure 2\">",
"      Carpal tunnel syndrome structures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/45/19158\" title=\"figure 3\">",
"      Cross section of wrist",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/44/38593\" title=\"figure 4\">",
"      Median sensory territory",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?33/62/34785\" title=\"figure 5\">",
"      Anatomy of the ulnar nerve at the elbow",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?23/56/24448\" title=\"figure 6\">",
"      Cutaneous sensory distribution of the ulnar nerve",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/0/15364\" title=\"figure 7\">",
"      Major branches of the ulnar nerve at the wrist",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5282|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/47/1791\" title=\"picture 1\">",
"      Winging of scapula",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5282|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/56/908\" title=\"table 1\">",
"      Symptoms of cervical root lesions",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/53/2906?source=related_link\">",
"      Brachial plexus syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/19/36152?source=related_link\">",
"      Clinical features and diagnosis of cervical radiculopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42230?source=related_link\">",
"      Clinical manifestations and diagnosis of carpal tunnel syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/57/22423?source=related_link\">",
"      Clinical manifestations of vasculitic neuropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/53/16215?source=related_link\">",
"      Diagnosis and treatment of vasculitic neuropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/34/16938?source=related_link\">",
"      Diagnosis of amyotrophic lateral sclerosis and other forms of motor neuron disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/32/8712?source=related_link\">",
"      Differential diagnosis of peripheral nerve and muscle disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1354?source=related_link\">",
"      Epicondylitis (tennis and golf elbow)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/34/16934?source=related_link\">",
"      Epidemiology and classification of diabetic neuropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/22/23911?source=related_link\">",
"      Etiology of carpal tunnel syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/46/1769?source=related_link\">",
"      Overview of electromyography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42233?source=related_link\">",
"      Overview of lower extremity peripheral nerve syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/31/2554?source=related_link\">",
"      Overview of nerve conduction studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/12/7369?source=related_link\">",
"      Overview of polyneuropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/62/44008?source=related_link\">",
"      Treatment of carpal tunnel syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/47/17144?source=related_link\">",
"      Treatment of cervical radiculopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/12/38089?source=related_link\">",
"      Ulnar neuropathy at the elbow and wrist",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f8_44_8907="Causes of pleuritic chest pain";
var content_f8_44_8907=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F75028&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F75028&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of pleuritic chest pain",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Viral pleurisy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pneumonia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute pulmonary embolus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pneumothorax",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pericarditis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Collagen vascular diseases, including systemic lupus erythematosus, mixed connective tissue disease, and rheumatoid arthritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Drug-induced lupus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inflammatory bowel disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Familial Mediterranean fever",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Radiation pneumonitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pulmonary histoplasmosis, infection with the lung fluke Paragonimus",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_44_8907=[""].join("\n");
var outline_f8_44_8907=null;
var title_f8_44_8908="Good sleep hygiene";
var content_f8_44_8908=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F50224&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F50224&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Good sleep hygiene",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        During the day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Exercise regularly. Even a 20-minute walk during the day can help you relax. Don't exercise in the evening.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Limit naps if you can. If you must nap, limit your nap to 30 minutes.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Before bedtime",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Avoid alcohol, caffeine, chocolate, and nicotine in the late afternoon and evening.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Limit liquids in the evening before going to bed.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Turn off the TV&nbsp;one hour before bedtime. Listen to quiet music or take a warm bath.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        If you worry or \"can't turn your brain off\" when you try to sleep, make a list of things you need to do before you go to bed and then stop thinking about them.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        At bedtime",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Go to bed and get up at the same time every day, even on weekends.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        A bedtime snack of warm milk, turkey, or a banana may make you sleepy.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Use your bedroom only for sleep and sex, no reading, watching TV, or working.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        If you are a \"clock watcher\", turn your clock so that you cannot see its face.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        To fall asleep, lie in the position that you normally find yourself in when you wake up.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Go to bed at the same time with your spouse.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        If you can't fall asleep",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        If you haven't fallen asleep in 15 minutes, go to another room. Listen to quiet music. Avoid things that stimulate your mind (TV, exciting books). Reading self-help books may help you feel drowsy. Go back to bed when you feel sleepy. If you still can't fall asleep, get up again and repeat as necessary.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        If you wake up during the night",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        If you can't get back to sleep, follow the procedure above (if you can't fall asleep).",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_44_8908=[""].join("\n");
var outline_f8_44_8908=null;
var title_f8_44_8909="Acute iron intoxication - Rapid overview";
var content_f8_44_8909=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F61711&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F61711&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Acute iron intoxication: Rapid overview",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        <span style=\"color: #ff0000;\">",
"         To obtain emergent consultation with a medical toxicologist, call the United States Poison Control Network at 1-800-222-1222, or access the World Health Organization's list of international poison centers (",
"        </span>",
"        <a href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\" target=\"_blank\">",
"         www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"        </a>",
"        <span style=\"color: #ff0000;\">",
"         ).",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        History",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        What form of iron was ingested?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Ferrous gluconate (12 percent elemental iron)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Ferrous sulfate (20 percent elemental iron)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Ferrous fumarate (33 percent elemental iron)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        How many mg/kg of elemental iron was ingested?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        When did the ingestion occur?",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Clinical features: overlapping phases of clinical manifestations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gastrointestinal phase: (30 minutes to 6 hours) abdominal pain, vomiting, diarrhea, hematemesis, melena, lethargy, shock (from capillary leak and third spacing), metabolic acidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Latent: (6 to 24 hours) improvement in GI symptoms; may have poor perfusion, tachypnea, tachycardia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Shock and metabolic acidosis: (4 hours to 4 days) hypovolemic, distributive, or cardiogenic shock with profound metabolic acidosis, coagulopathy, renal insufficiency/failure, pulmonary dysfunction/failure, central nervous system dysfunction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatotoxicity: (within 2 days) coma, coagulopathy, jaundice. Severity is dose dependent.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bowel obstruction: (2 to 4 weeks) vomiting, dehydration, abdominal pain, usually gastric outlet obstruction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Diagnostic evaluation: for all patients with systemic symptoms, those who have ingested &gt;40 mg/kg of elemental iron, and those for whom the amount of elemental iron ingested is unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Serum iron concentration: measure serum iron concentration within 4 to 6 hours after ingestion (8 hours for extended release tablets)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Arterial or venous pH",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abdominal radiograph looking for radiopaque pills",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Other initial labs: electrolytes, BUN, creatinine, glucose, liver function tests, prothrombin, partial thromboplastin time, CBC with differential, type and cross match",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Management",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Secure airway and breathing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Treat volume depletion aggressively with isotonic infusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Whole bowel irrigation: for all patients with a significant number of pills in stomach and small intestine on radiograph",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Deferoxamine: continuous IV infusion (can cause hypotension). Begin at 15 mg/kg/hour. May increase to 35/mg/kg/hour during first 24 hours for severe ingestions. A toxicologist and/or regional poison control center should be consulted to determine the optimum dose of deferoxamine and duration of therapy. Treat in the following circumstances:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Severe symptoms: altered mental status, hemodynamic instability, persistent vomiting, diarrhea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Anion gap metabolic acidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Serum iron concentration &gt;500 mcg/dL",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Significant number of pills on x-ray",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_44_8909=[""].join("\n");
var outline_f8_44_8909=null;
var title_f8_44_8910="Coagulation test Fullterm NB";
var content_f8_44_8910=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F52172&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F52172&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Reference values for coagulation tests in the healthy full-term infant during the first 6 months of life",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Tests",
"      </td>",
"      <td class=\"subtitle1\">",
"       Day 1 (n)",
"      </td>",
"      <td class=\"subtitle1\">",
"       Day 5 (n)",
"      </td>",
"      <td class=\"subtitle1\">",
"       Day 30 (n)",
"      </td>",
"      <td class=\"subtitle1\">",
"       Day 90 (n)",
"      </td>",
"      <td class=\"subtitle1\">",
"       Day 180 (n)",
"      </td>",
"      <td class=\"subtitle1\">",
"       Adult (n)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       PT (s)",
"      </td>",
"      <td>",
"       13.0 &plusmn; 1.43 (61)*",
"      </td>",
"      <td>",
"       12.4 &plusmn; 1.46 (77)*&bull;",
"      </td>",
"      <td>",
"       11.8 &plusmn; 1.25 (67)*&bull;",
"      </td>",
"      <td>",
"       11.9 &plusmn; 1.15 (62)*",
"      </td>",
"      <td>",
"       12.3 &plusmn; 0.79 (47)*",
"      </td>",
"      <td>",
"       12.4 &plusmn; 0.78 (29)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       APTT (s)",
"      </td>",
"      <td>",
"       42.9 &plusmn; 5.80 (61)",
"      </td>",
"      <td>",
"       42.6 &plusmn; 8.62 (76)",
"      </td>",
"      <td>",
"       40.4 &plusmn; 7.42 (67)",
"      </td>",
"      <td>",
"       37.1 &plusmn; 6.52 (62)*",
"      </td>",
"      <td>",
"       35.5 &plusmn; 3.71 (47)*",
"      </td>",
"      <td>",
"       33.5 &plusmn; 3.44 (29)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       TCT (s)",
"      </td>",
"      <td>",
"       23.5 &plusmn; 2.38 (58)*",
"      </td>",
"      <td>",
"       23.1 &plusmn; 3.07 (64)&bull;",
"      </td>",
"      <td>",
"       24.3 &plusmn; 2.44 (53)*",
"      </td>",
"      <td>",
"       25.1 &plusmn; 2.32 (52)*",
"      </td>",
"      <td>",
"       25.5 &plusmn; 2.86 (41)*",
"      </td>",
"      <td>",
"       25.0 &plusmn; 2.66 (19)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Fibrinogen (g/L)",
"      </td>",
"      <td>",
"       2.83 &plusmn; 0.58 (61)*",
"      </td>",
"      <td>",
"       3.12 &plusmn; 0.75 (77)*",
"      </td>",
"      <td>",
"       2.70 &plusmn; 0.54 (67)*",
"      </td>",
"      <td>",
"       2.43 &plusmn; 0.68 (60)*&bull;",
"      </td>",
"      <td>",
"       2.51 &plusmn; 0.68 (47)*&bull;",
"      </td>",
"      <td>",
"       2.78 &plusmn; 0.61 (29)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       II (U/mL)",
"      </td>",
"      <td>",
"       0.48 &plusmn; 0.11 (61)",
"      </td>",
"      <td>",
"       0.63 &plusmn; 0.15 (76)",
"      </td>",
"      <td>",
"       0.68 &plusmn; 0.17 (67)",
"      </td>",
"      <td>",
"       0.75 &plusmn; 0.15 (62)",
"      </td>",
"      <td>",
"       0.88 &plusmn; 0.14 (47)",
"      </td>",
"      <td>",
"       1.08 &plusmn; 0.19 (29)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       V (U/mL)",
"      </td>",
"      <td>",
"       0.72 &plusmn; 0.18 (61)",
"      </td>",
"      <td>",
"       0.95 &plusmn; 0.25 (76)",
"      </td>",
"      <td>",
"       0.98 &plusmn; 0.18 (67)",
"      </td>",
"      <td>",
"       0.90 &plusmn; 0.21 (62)",
"      </td>",
"      <td>",
"       0.91 &plusmn; 0.18 (47)",
"      </td>",
"      <td>",
"       1.06 &plusmn; 0.22 (29)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       VII (U/mL)",
"      </td>",
"      <td>",
"       0.66 &plusmn; 0.19 (60)",
"      </td>",
"      <td>",
"       0.89 &plusmn; 0.27 (75)",
"      </td>",
"      <td>",
"       0.90 &plusmn; 0.24 (67)",
"      </td>",
"      <td>",
"       0.91 &plusmn; 0.26 (62)",
"      </td>",
"      <td>",
"       0.87 &plusmn; 0.20 (47)",
"      </td>",
"      <td>",
"       1.05 &plusmn; 0.19 (29)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       VIII (U/mL)",
"      </td>",
"      <td>",
"       1.00 &plusmn; 0.39 (60)*&bull;",
"      </td>",
"      <td>",
"       0.88 &plusmn; 0.33 (75)*&bull;",
"      </td>",
"      <td>",
"       0.91 &plusmn; 0.33 (67)*&bull;",
"      </td>",
"      <td>",
"       0.79 &plusmn; 0.23 (62)*&bull;",
"      </td>",
"      <td>",
"       0.73 &plusmn; 0.18 (47)&bull;",
"      </td>",
"      <td>",
"       0.99 &plusmn; 0.25 (29)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       vWF (U/mL)",
"      </td>",
"      <td>",
"       1.53 &plusmn; 0.67 (40)&bull;",
"      </td>",
"      <td>",
"       1.40 &plusmn; 0.57 (3)&bull;",
"      </td>",
"      <td>",
"       1.28 &plusmn; 0.59 (40)&bull;",
"      </td>",
"      <td>",
"       1.18 &plusmn; 0.44 (40)&bull;",
"      </td>",
"      <td>",
"       1.07 &plusmn; 0.45 (46)&bull;",
"      </td>",
"      <td>",
"       0.92 &plusmn; 0.33 (29)&bull;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       IX (U/mL)",
"      </td>",
"      <td>",
"       0.53 &plusmn; 0.19 (59)",
"      </td>",
"      <td>",
"       0.53 &plusmn; 0.19 (75)",
"      </td>",
"      <td>",
"       0.51 &plusmn; 0.15 (67)",
"      </td>",
"      <td>",
"       0.67 &plusmn; 0.23 (62)",
"      </td>",
"      <td>",
"       0.86 &plusmn; 0.25 (47)",
"      </td>",
"      <td>",
"       1.09 &plusmn; 0.27 (29)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       X (U/mL)",
"      </td>",
"      <td>",
"       0.40 &plusmn; 0.14 (60)",
"      </td>",
"      <td>",
"       0.49 &plusmn; 0.15 (76)",
"      </td>",
"      <td>",
"       0.59 &plusmn; 0.14 (67)",
"      </td>",
"      <td>",
"       0.71 &plusmn; 0.18 (62)",
"      </td>",
"      <td>",
"       0.78 &plusmn; 0.20 (47)",
"      </td>",
"      <td>",
"       1.06 &plusmn; 0.23 (29)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       XI (U/mL)",
"      </td>",
"      <td>",
"       0.38 &plusmn; 0.14 (60)",
"      </td>",
"      <td>",
"       0.55 &plusmn; 0.16 (74)",
"      </td>",
"      <td>",
"       0.53 &plusmn; 0.13 (67)",
"      </td>",
"      <td>",
"       0.69 &plusmn; 0.14 (62)",
"      </td>",
"      <td>",
"       0.86 &plusmn; 0.24 (47)",
"      </td>",
"      <td>",
"       0.97 &plusmn; 0.15 (29)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       XII (U/mL)",
"      </td>",
"      <td>",
"       0.53 &plusmn; 0.20 (60)",
"      </td>",
"      <td>",
"       0.47 &plusmn; 0.18 (75)",
"      </td>",
"      <td>",
"       0.49 &plusmn; 0.16 (67)",
"      </td>",
"      <td>",
"       0.67 &plusmn; 0.21 (62)",
"      </td>",
"      <td>",
"       0.77 &plusmn; 0.19 (47)",
"      </td>",
"      <td>",
"       1.08 &plusmn; 0.28 (29)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       PK (U/mL)",
"      </td>",
"      <td>",
"       0.37 &plusmn; 0.16 (45)&bull;",
"      </td>",
"      <td>",
"       0.48 &plusmn; 0.14 (51)",
"      </td>",
"      <td>",
"       0.57 &plusmn; 0.17 (48)",
"      </td>",
"      <td>",
"       0.73 &plusmn; 0.16 (46)",
"      </td>",
"      <td>",
"       0.86 &plusmn; 0.15 (43)",
"      </td>",
"      <td>",
"       1.12 &plusmn; 0.25 (29)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       HMW-K (U/mL)",
"      </td>",
"      <td>",
"       0.54 &plusmn; 0.24 (47)",
"      </td>",
"      <td>",
"       0.74 &plusmn; 0.28 (63)",
"      </td>",
"      <td>",
"       0.77 &plusmn; 0.22 (50)*",
"      </td>",
"      <td>",
"       0.82 &plusmn; 0.32 (46)*",
"      </td>",
"      <td>",
"       0.82 &plusmn; 0.23 (48)*",
"      </td>",
"      <td>",
"       0.92 &plusmn; 0.22 (29)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       XIIIa (U/mL)",
"      </td>",
"      <td>",
"       0.79 &plusmn; 0.26 (44)",
"      </td>",
"      <td>",
"       0.94 &plusmn; 0.25 (49)*",
"      </td>",
"      <td>",
"       0.93 &plusmn; 0.27 (44)*",
"      </td>",
"      <td>",
"       1.04 &plusmn; 0.34 (44)*",
"      </td>",
"      <td>",
"       1.04 &plusmn; 0.29 (41)*",
"      </td>",
"      <td>",
"       1.05 &plusmn; 0.25 (29)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       XIIIb (U/mL)",
"      </td>",
"      <td>",
"       0.76 &plusmn; 0.23 (44)",
"      </td>",
"      <td>",
"       1.06 &plusmn; 0.37 (47)*",
"      </td>",
"      <td>",
"       1.11 &plusmn; 0.36 (45)*",
"      </td>",
"      <td>",
"       1.16 &plusmn; 0.34 (44)*",
"      </td>",
"      <td>",
"       1.10 &plusmn; 0.30 (41)*",
"      </td>",
"      <td>",
"       0.97 &plusmn; 0.20 (29)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Plasminogen (CTA, U/mL)",
"      </td>",
"      <td>",
"       1.95 &plusmn; 0.35 (44)",
"      </td>",
"      <td>",
"       2.17 &plusmn; 0.38 (60)",
"      </td>",
"      <td>",
"       1.98 &plusmn; 0.36 (52)",
"      </td>",
"      <td>",
"       2.48 &plusmn; 0.37 (44)",
"      </td>",
"      <td>",
"       3.01 &plusmn; 0.40 (47)",
"      </td>",
"      <td>",
"       3.36 &plusmn; 0.44 (29)",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    All factors except fibrinogen and plasminogen are expressed as units per milliliter where pooled plasma contains 1.0 U/mL. Plasminogen units are those recommended by the Committee on Thrombolytic Agents (CTA). AU values are expressed as mean &plusmn; 1 SD.",
"    <div class=\"footnotes\">",
"     VIII: factor VIII procoagulant.",
"     <br>",
"      * Values that do not differ statistically from the adult values.",
"      <br>",
"       &bull; These measurements are skewed because of a disproportionate number of high values. The lower limit that excludes the lower 2.5th percentile of the population has been given in the respective figure. The lower limit for factor VIII was 0.50 U/mL at all time points for the infant.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted from: Andrew, M, Paes, B, Milner, R, et al. Development of the Human Coagulation System in the Full-Term Infant. Blood 1987; 70:165. Copyright &copy; American Society of Hematology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_44_8910=[""].join("\n");
var outline_f8_44_8910=null;
var title_f8_44_8911="Bankart lesion AP radiograph";
var content_f8_44_8911=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F54398&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F54398&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bankart lesion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 336px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bankart lesions occur when the glenoid labrum is disrupted with dislocation. Most involve soft tissue but a small percentage involve the avulsion of bone fragments, as seen in this AP radiograph (black arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Mary Hochman, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f8_44_8911=[""].join("\n");
var outline_f8_44_8911=null;
